Malignant neoplasm of digestive organs

C3_DIGESTIVE_ORGANS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_OESOPHAGUS C3_STOMACH C3_SMALL_INTESTINE C3_COLON C3_RECTOSIGMOID_JUNCTION C3_RECTUM C3_ANUS_ANALCANAL C3_BILIARY_GALLBLADDER C3_PANCREAS C3_DIGESTIVE_ORGANS_NAS	23317
6. Filter based on genotype QC (FinnGen only)	20895

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9

NAME	C3_DIGESTIVE_ORGANS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_OESOPHAGUS\|C3_STOMACH\|C3_SMALL_INTESTINE\|C3_COLON\|C3_RECTOSIGMOID_JUNCTION\|C3_RECTUM\|C3_ANUS_ANALCANAL\|C3_BILIARY_GALLBLADDER\|C3_PANCREAS\|C3_DIGESTIVE_ORGANS_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of digestive organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	20895	8408	12487
Unadjusted period prevalence (%)	4.62	2.99	5.73
Median age at first event (years)	69.80	68.93	70.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20997: Matched controls
160493

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K83.0

ICD-10 Finland

Cholangitis

6.2

321.4

618

775

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

32.3

321.3

255

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.0

319.0

359

214

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

317.0

2273

7325

JMA10

NOMESCO Finland

Transabdominal total splenectomy

22.3

315.6

280

107

Kela drug reimbursment

Pernicious anaemia

4.8

312.0

797

1314

SPAT1125

SPAT

Stoma care and guidance

5.6

310.0

660

919

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

531

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

2713

D77

ICPC

Malignant digestive neopl other/NOS

331.9

307.7

467

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

896

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

21.3

307.7

3044

1267

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4037.3

307.7

523

WX402

NOMESCO Finland

General anaesthesia

3.3

307.7

5954

17385

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.7

307.7

436

204

JN4CD

NOMESCO Finland

Very extensive body CT

18.0

307.7

1962

916

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

55.2

307.7

264

WF002

NOMESCO Finland

Radical radiotherapy

97.6

307.7

1463

123

D75

ICPC

Malignant neoplasm colon/rectum

272.9

307.7

1116

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

310.9

307.7

399

L02AE02

ATC

leuprorelin; implant, parenteral

29.8

307.7

613

162

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

639

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3930.1

307.7

2743

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.3

307.7

1718

1924

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

307.7

3752

14823

A04AA02

ATC

granisetron; systemic, transdermal

1095.5

307.7

5101

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

5813.9

307.7

1435

ZX070

NOMESCO Finland

Intensity modified radiotherapy

560.7

307.7

502

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

18.1

307.7

517

224

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

307.7

769

WX302

NOMESCO Finland

Thoracal epidural anesthesy

30.5

307.7

4756

1524

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

114.8

307.7

340

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

271.3

307.7

349

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

22.9

307.7

353

120

ZX090

NOMESCO Finland

Other technic of radiotherapy

245.8

307.7

624

R4110

NOMESCO Finland

Physiotherapy

1.9

307.7

5984

27969

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

307.7

1833

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

307.7

913

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

9.5

307.7

897

754

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

52.0

307.7

698

106

369

Kela drug reimbursment

Regorafenib

+∞

307.7

370

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

31.4

307.7

360

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

5063.1

307.7

650

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

506.6

307.7

391

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

485

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

30.1

307.7

334

Z51.5

ICD-10 Finland

Palliative care

17.9

307.7

5716

3281

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.8

307.7

2793

4107

R50.9

ICD-10 Finland

Fever, unspecified

2.3

307.7

3421

12278

L02BG04

ATC

letrozole; oral

24.4

307.7

524

168

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

27.7

307.7

793

227

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

2847.0

307.7

735

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

8026

33133

H02AB02

ATC

dexamethasone; systemic

80.4

307.7

6310

853

115

Kela drug reimbursment

Breast cancer

+∞

307.7

748

JAH01

NOMESCO Finland

Laparoscopy

6.0

307.7

1549

2092

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

74.0

307.7

510

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

16384.0

307.7

2491

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

3653.0

307.7

475

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

90.7

307.7

1712

157

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

259.7

307.7

785

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

185.8

307.7

264

WF003

NOMESCO Finland

Adjuvant radiotherapy

207.4

307.7

529

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4008.8

307.7

1015

L01BC59

ATC

trifluridine, combinations; systemic

+∞

307.7

518

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

694.5

307.7

2413

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.0

307.7

306

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

307.7

1327

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1320.0

307.7

491

WZC00

NOMESCO Finland

Treatment plan or consultation

3.4

307.7

9320

30549

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

5599.4

307.7

1386

WX600

NOMESCO Finland

Single shot through catheter

25.5

307.7

898

281

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

307.7

491

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2342.8

307.7

611

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

2992.6

307.7

392

176

Kela drug reimbursment

Regorafenib

+∞

307.7

380

L03AA02

ATC

filgrastim; parenteral

150.1

307.7

1010

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

307.7

476

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

29.3

307.7

369

JG1BG

NOMESCO Finland

MRI of rectum

168.1

307.7

865

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

307.7

934

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.0

307.7

2064

5635

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

307.7

1861

JN4BD

NOMESCO Finland

Extensive body CT

15.7

307.7

5511

3549

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

307.7

347

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

2945.3

307.7

759

B01AB10

ATC

tinzaparin; parenteral

4.7

307.7

3698

6986

WF001

NOMESCO Finland

Preoperative radiotherapy

4983.5

307.7

1244

WX408

NOMESCO Finland

General anesthesy, balanced

3.0

307.7

6703

21906

ZXC96

NOMESCO Finland

Robot assisted procedure

15.8

307.7

504

249

PJA12

NOMESCO Finland

Sentinel node biopsy

361.3

307.7

730

JLC30

NOMESCO Finland

Pancreatoduodenectomy

95.5

307.7

654

TJF80

NOMESCO Finland

Ostomy education

37.3

307.7

906

194

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

307.7

4823

11009

HAC20

NOMESCO Finland

Total mastectomy

137.8

307.7

337

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

37.1

307.7

386

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

997.6

307.7

1570

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

18.3

307.7

337

143

Y77

ICPC

Malignant neoplasm prostate

140.0

307.7

413

ZX120

NOMESCO Finland

Intravenous

4.1

307.7

2677

5587

B01AB05

ATC

enoxaparin; parenteral

3.8

307.7

10108

31250

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

122.8

307.7

1283

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

225.2

307.7

1377

D70.82

ICD-10 Finland

Drug-induced neutropenia

19.0

307.7

398

163

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

131.4

307.7

305

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.6

307.7

1404

3113

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

108.4

307.7

335

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

1486

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

47.8

307.7

278

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

7.1

307.7

981

1107

JN4AD

NOMESCO Finland

Body CT examination

13.0

307.7

6388

5214

UJG02

NOMESCO Finland

Proctoscopy

6.1

307.7

955

1252

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

307.7

989

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

760

B01AB04

ATC

dalteparin; parenteral

3.9

307.7

1607

3308

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

16.3

307.7

1364

681

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

6.0

307.7

711

931

WF049

NOMESCO Finland

Radiotherapy of metastasis

1191.0

307.7

1300

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.4

307.7

738

696

A06AH03

ATC

naloxegol; oral

24.9

307.7

730

232

JFB43

NOMESCO Finland

Left hemicolectomy

23.1

307.7

435

147

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

1522.9

307.7

406

C20

ICD-10 Finland

Malignant neoplasm of rectum

5599.4

307.7

1386

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

864

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

26.1

307.7

405

121

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3719

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1082.4

307.7

413

L03AA13

ATC

pegfilgrastim; parenteral

1535.2

307.7

997

A04AA01

ATC

ondansetron; systemic, rectal

14.7

307.7

3376

2061

H01CB03

ATC

lanreotide; parenteral

187.5

307.7

338

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

307.7

357

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.8

307.7

1321

2812

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

10.8

307.7

522

377

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

16384.0

307.7

2156

TPH07

NOMESCO Finland

Cathetrisation of artery

4.6

307.7

4557

9138

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

307.7

357

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

819.2

307.7

923

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

307.7

1225

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

26.3

307.7

723

217

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

11.5

307.7

931

644

A04AA55

ATC

palonosetron, combinations; systemic

4614.8

307.7

1158

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.1

307.7

776

1010

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

571.0

307.7

511

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

51.1

307.7

1019

160

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

454

JFB46

NOMESCO Finland

Resection of sigmoid colon

9.7

307.7

572

464

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

307.7

405

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

8.7

307.7

626

566

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

718.8

307.7

550

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

10.5

307.7

3741

3249

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.5

307.7

4375

6247

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

898

N02AA05

ATC

oxycodone; systemic

5.8

307.7

7840

15036

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4306.0

307.7

1589

WW500

NOMESCO Finland

Blood transfusion

9.7

307.7

1451

1218

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

307.7

4558

18201

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

10830

57946

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.8

307.7

3284

7388

JFB30

NOMESCO Finland

Right hemicolectomy

46.8

307.7

1497

263

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

9.5

307.7

2174

1933

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

525

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.9

307.7

1745

1121

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

1693.2

307.7

667

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

14731

88893

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

385.7

307.7

1543

WF004

NOMESCO Finland

Palliative radiotherapy

983.4

307.7

745

C61

ICD-10 Finland

Malignant neoplasm of prostate

329.3

307.7

1593

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.2

307.7

830

802

WZC30

NOMESCO Finland

Teaching

4.4

307.7

5446

11722

K56.7

ICD-10 Finland

Ileus, unspecified

6.1

307.7

744

954

K83.1

ICD-10 Finland

Obstruction of bile duct

18.0

307.7

1057

471

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.0

307.7

949

1256

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.1

307.7

1116

1741

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

856

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

3668.9

307.7

477

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

307.7

632

ZXE20

NOMESCO Finland

More than three and less than five hours

3.0

307.7

3694

10764

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

799

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

12.4

307.7

956

617

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

307.7

406

JFB00

NOMESCO Finland

Partial resection of small intestine

11.4

307.7

990

693

R4190

NOMESCO Finland

Nutritional therapy

8.1

307.7

1556

1575

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1136.5

307.7

431

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

307.7

919

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

130.1

307.7

219

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

489

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

302.8

307.7

427

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

48.2

307.7

986

164

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

307.7

3098

11168

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

307.7

444

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.2

307.7

784

994

L01BC06

ATC

capecitabine; oral

+∞

307.7

6349

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

231.0

307.7

298

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

3312

10901

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

27.5

307.7

413

117

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.7

307.7

1202

1438

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

17.3

307.7

1195

559

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.7

307.7

1397

1996

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

743

A04AD12

ATC

aprepitant; systemic

1102.9

307.7

692

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4005.2

307.7

519

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

307.7

2750

6804

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

1463.6

307.7

391

H01CB02

ATC

octreotide; parenteral

69.9

307.7

271

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5855.3

307.7

747

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

307.7

459

R18

ICD-10 Finland

Ascites

8.3

307.7

859

823

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

66.4

307.7

467

UJF32

NOMESCO Finland

Coloscopy

4.4

307.7

10059

27894

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

11.9

307.7

925

619

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

4131

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

307.7

390

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

750

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

307.7

959

L02BA01

ATC

tamoxifen; oral

52.9

307.7

260

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

92.0

307.7

528

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

17.2

307.7

1213

569

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

5144.0

307.7

2421

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

307.7

439

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

42.9

307.7

407

JAH00

NOMESCO Finland

Laparotomy

8.1

307.7

1376

1375

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

307.7

414

A03FA01

ATC

metoclopramide; systemic, rectal

14.6

307.7

10632

10563

A79

ICPC

Malignancy NOS

172.9

307.7

721

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

7.6

307.7

826

863

XX3DW

NOMESCO Finland

Time consuming IT work

7.7

307.7

2951

3339

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

11.1

307.7

1561

1157

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

5807

21585

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

307.7

684

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

3087.7

307.7

404

Z93.3

ICD-10 Finland

Colostomy status

40.7

307.7

750

146

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.9

307.7

1415

2894

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

18.1

307.7

974

429

JG1CG

NOMESCO Finland

Extensive MRI of rectum

110.3

307.7

698

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

22.9

307.7

872

303

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2048.5

307.7

3744

UJK02

NOMESCO Finland

ERCP

6.9

307.7

1367

1613

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

307.7

3414

9690

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

11061

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

307.7

535

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

49.9

307.7

948

152

C16.00

ICD-10 Finland

Cardia

+∞

307.7

354

JFF10

NOMESCO Finland

Loop enterostomy

33.8

307.7

446

103

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.6

307.7

293

105

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

307.7

475

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

17.7

307.7

2063

983

JFF23

NOMESCO Finland

Transversostomy

61.2

307.7

1229

163

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

74.9

307.7

544

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

27.7

306.6

254

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

306.3

326

ZX080

NOMESCO Finland

Image guided radiotherapy

649.8

306.3

335

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

49.0

305.8

222

JKA20

NOMESCO Finland

Cholecystectomy

4.1

305.2

948

1833

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.9

305.1

436

381

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

304.5

324

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

40.8

301.8

227

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

301.6

321

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.9

301.3

614

818

D76

ICPC

Malignant neoplasm pancreas

290.2

300.9

338

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.0

300.2

397

310

JAL30

NOMESCO Finland

Omentectomy

17.2

300.0

295

133

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

299.7

319

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

12.6

297.0

340

209

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

1276.3

296.1

320

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

296.0

315

XX2RW, ,

NOMESCO Finland

9.8

295.7

396

315

JDE00

NOMESCO Finland

Gastrojejunostomy

65.6

294.1

204

L02BB03

ATC

bicalutamide; oral

822.1

292.2

318

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

416.8

291.6

323

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

291.3

310

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

291.3

310

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

287.5

306

J01MA12

ATC

levofloxacin; systemic

2.0

283.3

4167

17967

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

52.2

282.7

203

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

402.3

281.3

312

A06AD11

ATC

lactulose; oral

2.0

277.8

3754

15697

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

42.5

273.6

204

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.2

268.7

800

1495

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1132.0

266.0

288

JLC10

NOMESCO Finland

Distal pancreatectomy

33.6

265.9

209

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

45.6

265.1

195

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

91.0

265.1

177

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

264.9

282

WZC15, ,

NOMESCO Finland

28.4

264.0

217

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

1118.6

263.2

285

JN6AD

NOMESCO Finland

CT of torso and neck

9.6

262.8

356

288

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

262.8

7083

36666

JJB10

NOMESCO Finland

Atypcal resection of liver

283.3

261.4

294

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

261.3

1658

5008

K92.1

ICD-10 Finland

Melaena

2.7

259.9

1599

4753

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.4

259.5

385

354

Z43.3

ICD-10 Finland

Attention to colostomy

38.8

257.8

196

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

256.4

273

Z93

ICD-10 Finland

Artificial opening status

33.2

256.2

202

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

543.4

255.7

281

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

254.9

2382

8608

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

21.3

250.5

226

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

248.9

265

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

242.3

258

Z51.0

ICD-10 Finland

Radiotherapy session

345.8

241.2

269

TPX15

NOMESCO Finland

Removal of vascular injection port

18.8

240.2

227

ZZR00

NOMESCO Finland

Flap of skin

8.8

239.8

344

302

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

9.7

239.2

321

256

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

239.2

1414

4111

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

238.5

254

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

238.0

1211

3241

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

237.9

7187

38115

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

235.7

251

Z31.5

ICD-10 Finland

Genetic counselling

3.7

235.1

837

1785

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.2

234.4

449

560

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.2

232.7

450

567

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.1

231.8

707

1345

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

15.0

230.7

241

124

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

12.2

230.0

268

170

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

31.3

228.8

183

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

64.4

228.6

159

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

33.6

227.9

179

ZX121

NOMESCO Finland

Central venous catheter

27.9

227.6

188

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

227.2

242

WX704

NOMESCO Finland

Intubation

2.4

226.9

1818

6129

WPB10

NOMESCO Finland

Making a convalescent care decision

22.9

226.4

199

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.7

226.0

257

156

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.8

225.7

1245

3484

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.7

225.0

284

206

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

220.6

235

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

1774.0

220.2

237

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

272.4

220.1

248

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

219.7

234

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

219.7

234

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

20.6

218.9

200

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

218.1

1184

3283

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

217.8

232

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.8

217.8

272

194

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

215.9

230

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

6.4

214.5

399

482

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.3

214.5

355

375

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

214.0

228

XX1AD

NOMESCO Finland

Other CT-examination

63.7

213.9

149

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

213.1

227

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

888.2

211.6

230

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

211.2

225

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

211.2

225

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

211.2

225

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

211.2

225

E34.0

ICD-10 Finland

Carcinoid syndrome

207.6

210.8

241

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

209.3

223

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

208.4

222

198

Kela drug reimbursment

Sorafenib

+∞

207.5

221

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

207.5

221

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

51.8

205.8

148

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

205.5

1490

4789

1XC07, ,

NOMESCO Finland

1618.1

201.4

217

C50.99

ICD-10 Finland

Breast, unspecified

289.5

201.2

226

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

199.9

213

JFB50

NOMESCO Finland

Other resection of colon

19.4

199.1

186

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

199.0

212

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

199.0

212

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

198.1

1000

2659

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

198.0

211

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

25.0

198.0

169

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

218.2

197.4

225

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

196.5

964

2521

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.1

196.1

602

1150

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.8

195.7

281

247

N02AA01

ATC

morphine; systemic, rectal

4.7

194.8

505

841

L01BC53

ATC

tegafur, combinations; systemic

+∞

190.5

203

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

188.6

201

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.3

187.8

259

215

HA1AA

NOMESCO Finland

X-ray mammography

3.2

187.1

826

2027

TJA10

NOMESCO Finland

Laparocentesis

31.9

187.1

149

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

186.8

199

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

186.8

199

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

45.8

186.4

137

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

185.8

198

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

38.7

185.5

141

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

51.1

184.5

133

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

53.4

184.5

132

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

183.9

196

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

18.5

183.8

175

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

183.0

2472

10210

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

86.0

183.0

123

ZX050

NOMESCO Finland

Stereotactic radiotherapy

25.8

182.1

154

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

182.1

194

N02AX02

ATC

tramadol; systemic, rectal

1.5

182.1

8824

51450

Z43.2

ICD-10 Finland

Attention to ileostomy

33.3

181.6

143

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

33.3

181.6

143

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

181.1

193

ZXD05

NOMESCO Finland

Urgent procedure

1.6

180.2

5839

31033

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

180.2

192

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

180.1

1385

4567

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

179.6

1046

3007

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.9

178.3

948

2594

R11

ICD-10 Finland

Nausea and vomiting

2.1

177.0

1846

6925

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

175.5

187

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

9.1

175.5

245

207

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

1400.6

175.1

189

JFB40

NOMESCO Finland

Resection of transverse colon

32.9

173.5

137

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

55.6

173.0

123

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

62.0

173.0

121

L01EX05

ATC

regorafenib; oral

+∞

172.7

184

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.9

172.0

346

454

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

8.7

171.6

249

222

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

35.3

171.2

133

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.8

171.1

570

1157

D99

ICPC

Disease digestive system other

5.5

170.7

366

512

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

1361.8

170.4

184

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

1448.4

166.7

180

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

164.7

7097

40081

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

164.2

175

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

163.5

807

2115

JF2AB

NOMESCO Finland

Colongraphy with X-ray

17.5

163.2

159

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.2

162.9

156

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

162.3

173

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

162.3

173

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

162.3

173

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

162.3

173

WW200, ,

SPAT

0.6

162.1

3157

37489

JFF24

NOMESCO Finland

Laparoscopic transversostomy

52.4

161.6

116

L02BG03

ATC

anastrozole; oral

41.9

160.5

120

L01AX03

ATC

temozolomide; systemic

+∞

160.4

171

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

160.4

171

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

159.5

170

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

158.5

2249

9419

ZX112

NOMESCO Finland

Subcutaneous

6.5

158.5

292

349

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

46.9

158.5

116

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

232.7

158.5

180

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

19.3

158.2

148

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

157.6

168

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

157.6

168

C10AA07

ATC

rosuvastatin; oral

0.6

157.1

4019

44694

WPA13

NOMESCO Finland

Palliative consultation

12.3

156.7

181

113

JJA20

NOMESCO Finland

Open biopsy of liver

18.9

155.7

147

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.4

155.6

438

781

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

654.3

155.4

170

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

155.1

1127

3614

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

154.8

165

WX002

NOMESCO Finland

Sedation and analgesia

1.7

154.3

3893

19319

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

152.0

162

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.8

151.8

267

303

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

58.7

151.7

107

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

58.7

151.7

107

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

151.5

2730

33206

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.2

151.2

348

521

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.7

151.1

540

1152

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

222.0

151.1

172

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

151.0

161

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.0

150.9

745

1952

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

150.7

150.9

176

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

634.9

150.8

165

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

150.1

1295

4484

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

149.6

920

2717

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

13.1

149.5

167

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.7

149.3

386

641

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

149.2

159

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

149.2

159

L01XE21

ATC

[U] regorafenib

+∞

148.2

158

E0000UV, ,

ATC

1.5

148.1

7804

45693

V03AF03

ATC

calcium folinate; systemic

316.4

147.5

165

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.0

147.4

290

372

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

147.3

157

JGB36

NOMESCO Finland

Wide excision of rectum

1257.9

147.0

159

B81

ICPC

Anaemia vit B12/folate deficiency

2.5

146.3

1009

3155

A98

ICPC

Health maint/preventive medicine

0.6

146.2

16663

138137

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

15.7

145.9

149

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

+∞

145.4

155

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

32.7

145.4

115

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

56.5

145.2

103

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

21.6

143.8

129

SPAT1262

SPAT

Handing over of treatment supplies

1.6

143.6

3777

18903

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

143.5

153

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

143.2

679

1737

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

142.6

152

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

52.2

142.0

102

L02AE04

ATC

triptorelin; parenteral

59.1

141.9

100

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

15.0

141.8

148

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.8

140.9

286

379

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.8

140.8

483

1001

Z93.2

ICD-10 Finland

Ileostomy status

11.0

140.8

174

122

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

12.3

139.0

161

101

JFB20

NOMESCO Finland

Ileocaecal resection

9.0

139.0

196

168

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

138.8

148

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

138.8

148

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.4

138.8

542

1228

Z3231

NOMESCO Finland

Registered nurse

1.5

138.4

5045

27249

WX892

NOMESCO Finland

Monitored bed care

2.0

138.1

1661

6551

JJB71

NOMESCO Finland

Laparoscopic resection of liver

240.4

136.8

155

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

136.3

722

1968

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.9

136.1

697

1864

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

135.8

457

934

C209, 8148, 2

ICD-O-3

22.5

135.8

120

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

135.8

835

2465

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

31.9

135.7

108

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

50.2

135.5

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.5

135.1

198

179

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

135.1

144

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

10.6

134.9

170

123

T73

ICPC

Neoplasm endocrine other/unspecified

36.3

134.8

104

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

133.2

142

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

37.3

133.0

102

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

16.6

132.7

132

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

132.1

896

2777

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

59.5

132.1

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

9.6

131.4

177

142

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

131.3

140

C50

ICD-10 Finland

Malignant neoplasm of breast

167.2

131.3

152

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

230.8

131.2

149

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

147.2

131.0

153

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

130.4

139

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.7

130.1

269

363

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.8

130.1

326

527

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.6

129.3

848

2585

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

277.5

128.9

145

JJB30

NOMESCO Finland

Excision of two segments of liver

189.9

128.9

148

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

127.6

136

KC1GB

NOMESCO Finland

Cystography with X-ray

17.2

127.4

125

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

126.6

135

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

16.4

125.9

126

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

125.7

134

JN4DD

NOMESCO Finland

Scout CT scan of torso

53.1

125.6

C25

ICD-10 Finland

Malignant neoplasm of pancreas

269.7

125.2

141

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.5

124.6

183

166

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

352.7

123.9

138

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

+∞

123.8

132

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

123.8

132

D74

ICPC

Malignant neoplasm stomach

216.4

122.9

140

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

122.9

131

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

122.9

131

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

26.4

122.7

103

J01MA02

ATC

ciprofloxacin; systemic

1.4

122.6

7651

45798

ZXE00

NOMESCO Finland

One hour or less

1.4

122.2

6845

40149

XW000

NOMESCO Finland

Bone marrow biopsy

3.0

122.0

587

1514

S77

ICPC

Malignant neoplasm of skin

15.5

121.7

125

WX610

NOMESCO Finland

Patient controlled analgesia

7.5

121.5

197

203

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

121.0

129

C03CA01

ATC

furosemide; systemic

1.4

120.8

7019

41434

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.3

120.7

1001

3401

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

59.3

120.6

WGA11

NOMESCO Finland

Planning of pain management

8.0

120.4

185

178

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

120.0

128

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

119.1

127

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

118.2

126

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

38.4

118.1

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

28.3

116.8

JFF13

NOMESCO Finland

Terminal enterostomy

12.2

116.3

135

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

116.3

124

WX004

NOMESCO Finland

Patient-controlled sedation

6.7

116.2

206

236

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

968.4

116.1

126

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

115.4

123

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

115.3

1506

6102

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

11.1

114.7

141

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

114.4

122

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

114.4

122

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

114.4

122

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

114.4

122

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

114.4

411

880

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

114.3

3194

16128

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

952.9

114.2

124

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.8

113.7

286

464

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

113.5

121

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

945.2

113.3

123

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

112.5

120

323

Kela drug reimbursment

Sorafenib

+∞

112.5

120

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

112.5

120

L01XE05

ATC

[U] sorafenib

+∞

112.5

120

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

17.2

112.3

110

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

112.1

367

735

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

10.9

112.1

139

JDA63

NOMESCO Finland

Local excision of lesion of stomach

19.2

112.1

105

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

111.6

119

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.9

111.3

192

213

M01AH05

ATC

etoricoxib; oral

0.7

111.0

8349

77024

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

16.4

110.9

111

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

110.7

118

X76

ICPC

Malignant neoplasm breast female

164.1

110.5

128

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

922.0

110.5

120

C10AX09

ATC

ezetimibe; oral

0.6

109.9

1725

22076

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

109.7

117

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

109.7

117

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

109.7

117

JFF26

NOMESCO Finland

Sigmoidostomy

18.6

109.6

104

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

26.2

109.3

UJF34

NOMESCO Finland

Left colonoscopy

5.4

109.1

237

336

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

14.4

109.0

116

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

123.0

108.1

128

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

107.8

115

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

107.8

115

M25.5

ICD-10 Finland

Pain in joint

0.6

107.3

3234

35365

128

Kela drug reimbursment

Cancers of female genital organs

306.1

107.2

120

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.0

106.5

530

1394

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

16.8

106.0

105

L02BX02

ATC

degarelix; parenteral

+∞

106.0

113

WX882

NOMESCO Finland

High dependency care

2.7

105.5

618

1777

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

105.0

112

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

105.0

112

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

875.6

104.9

114

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

875.6

104.9

114

WPA44, ,

SPAT

11.2

104.8

128

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

40.4

104.8

OAA41

NOMESCO Finland

Health check based on individual needs

42.7

104.6

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

52.3

104.3

JFC00

NOMESCO Finland

Entero-enterostomy

21.2

104.2

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

440.9

104.1

115

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

104.1

111

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.2

104.0

442

1057

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

103.1

110

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

860.1

103.0

112

189

Kela drug reimbursment

Imatinib

860.1

103.0

112

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

44.8

102.9

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

15.4

102.8

106

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

47.9

102.8

SPAT1255

SPAT

Intravenous administration of medicine

1.9

102.5

1376

5622

K65.0

ICD-10 Finland

Acute peritonitis

4.0

102.1

321

624

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

101.3

108

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

101.3

108

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

101.3

108

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

+∞

100.3

107

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.1

99.6

169

184

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

10.5

99.5

126

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

99.4

106

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

98.7

289

532

KA1FN

NOMESCO Finland

Isotope renography

6.9

98.6

171

191

WVA20

NOMESCO Finland

Medicine administration

2.7

98.4

583

1686

WPA43, ,

SPAT

19.1

98.0

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

280.2

97.9

110

JFC10

NOMESCO Finland

Ileotransversostomy

53.7

97.8

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

413.8

97.6

108

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

97.5

104

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.4

97.5

212

301

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

36.0

96.9

EB1VA, ,

NOMESCO Finland

0.6

96.7

1395

18351

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

96.6

103

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.2

96.4

415

1001

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

95.7

767

2564

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

798.3

95.5

104

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

272.5

95.2

107

1CD01, ,

NOMESCO Finland

+∞

94.7

101

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

167.5

94.3

109

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

398.3

93.9

104

Z3226

NOMESCO Finland

Physiotherapist

1.5

93.9

3198

16826

UKC02

NOMESCO Finland

Cystoscopy

1.6

93.9

2972

15385

TQW99

NOMESCO Finland

Other minor procedure on skin

2.4

93.8

728

2399

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

93.8

100

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

93.8

100

OAB43, ,

SPAT

0.5

93.7

1240

16738

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

93.4

1568

6875

A28

ICPC

Limited function/disability NOS

1.5

93.3

3886

21321

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.1

92.5

277

519

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

767.4

91.8

100

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

24.2

91.6

JFF00

NOMESCO Finland

Catheter enterostomy

43.5

91.5

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

20.5

90.9

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.3

90.6

378

894

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

10.9

90.3

112

KCC10

NOMESCO Finland

Cystoprostatectomy

198.1

90.1

103

C15.0

ICD-10 Finland

Malignant neoplasm: Cervical part of oesophagus

+∞

90.0

L01CB01

ATC

etoposide; systemic

+∞

90.0

JFA70

NOMESCO Finland

Suture of small intestine

8.2

89.5

135

127

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

89.4

651

2083

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

88.2

8530

76962

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

88.1

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

88.1

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

88.1

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

88.1

1056

4142

6434

FHL

Anterior resection

17.6

87.6

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

87.6

9809

86688

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

+∞

87.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

87.1

1297

5475

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

90.5

87.0

106

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.2

86.8

120

100

TQW20

NOMESCO Finland

Tatoe

18.2

86.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

367.4

86.4

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

86.3

D18

ICPC

Change in faeces/bowel movements

2.5

86.1

582

1798

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.8

86.1

289

590

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.4

85.7

333

752

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

23.0

85.5

SPAT1088

SPAT

Blood transfusion

7.2

85.4

142

151

EB4VA, ,

NOMESCO Finland

0.5

85.3

1049

14501

6404

FHL

Hemicolectomy on the right

17.0

85.2

K22.2

ICD-10 Finland

Oesophageal obstruction

4.0

84.7

261

500

A41.8

ICD-10 Finland

Other specified sepsis

2.9

84.7

441

1190

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

30.7

84.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

84.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

84.4

C24.02

ICD-10 Finland

Common bile duct

+∞

84.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

84.3

755

2646

M79.6

ICD-10 Finland

Pain in limb

0.7

84.1

5457

52431

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

4.9

83.7

203

319

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

+∞

83.4

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

83.4

381

953

L01XX05

ATC

hydroxycarbamide; oral

15.5

82.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

82.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

82.5

L01XE01

ATC

[U] imatinib

+∞

82.5

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

81.6

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

81.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

81.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

81.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

682.5

81.5

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

9.1

81.3

113

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

80.6

C24.00

ICD-10 Finland

Hepatic duct

+∞

80.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

80.5

2200

10979

SDA03

NOMESCO Finland

Periodontal treatment

0.7

80.1

4430

43770

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

340.3

79.9

JFF30

NOMESCO Finland

Other colostomy

15.9

79.9

N02BE01

ATC

paracetamol; systemic, rectal

1.4

79.8

17520

124692

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

7.0

79.8

136

149

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

79.7

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.0

79.7

251

489

Z94.4

ICD-10 Finland

Liver transplant status

8.2

79.5

120

113

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

17.1

79.4

JFC20

NOMESCO Finland

Other enterocolostomy

32.2

79.2

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

79.2

4710

46012

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

104.2

79.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.4

79.1

129

134

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.7

79.1

5413

51726

I81

ICD-10 Finland

Portal vein thrombosis

6.6

79.0

141

163

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.8

78.8

123

121

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

78.7

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

78.7

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.1

78.7

233

433

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

38.3

78.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

78.5

1357

5993

A10AB05

ATC

insulin aspart; parenteral

1.7

78.5

1539

7048

6322

FHL

Gastrectomy (including Roux-Y)

41.1

78.4

Z2221

NOMESCO Finland

Medical doctor

1.4

78.1

4440

25693

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

30.2

77.9

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

77.9

722

2566

R01AD58

ATC

fluticasone, combinations; nasal

0.6

77.6

1848

21522

YX9AW, ,

NOMESCO Finland

117.7

77.5

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

77.4

285

621

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

76.9

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

643.9

76.9

JJB20

NOMESCO Finland

Excision of single segment of liver

643.9

76.9

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

76.8

849

3231

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.0

76.7

242

472

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.8

76.7

427

1195

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.4

76.6

210

367

Z01.2

ICD-10 Finland

Dental examination

0.7

76.1

5309

50679

JAL00

NOMESCO Finland

Biopsy of peritoneum

10.9

76.0

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

75.9

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

75.9

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

6.8

75.3

131

147

L15

ICPC

Knee symptom/complaint

0.7

75.2

2719

29038

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

135.1

75.0

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

75.0

SPAT1153

SPAT

Removal of sutures

1.4

74.1

5537

33464

UJD02

NOMESCO Finland

Gastroscopy

1.9

74.1

986

4007

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

74.1

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

74.1

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

74.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.4

73.9

288

652

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

15.5

73.2

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

73.1

318

772

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

73.1

L01EX02

ATC

sorafenib; oral

+∞

73.1

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

73.0

1005

4131

M03BX02

ATC

tizanidine; oral

0.8

72.9

8361

74559

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

72.3

1262

5586

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

15.1

72.3

WPA44

NOMESCO Finland

Nursing home for palliative care

10.8

72.2

L02BG06

ATC

exemestane; oral

605.4

72.2

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

72.2

999

4113

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

72.1

4678

45254

XKD00

NOMESCO Finland

Uroflowmetry

1.5

71.8

2723

14578

C90.0

ICD-10 Finland

Multiple myeloma

305.5

71.6

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

128.9

71.4

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

71.2

L01EA01

ATC

imatinib; oral

+∞

71.2

WZC00, ,

SPAT

0.6

71.2

1255

15755

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

108.7

71.2

OAA67, ,

SPAT

0.5

70.9

661

10019

N05CF01

ATC

zopiclone; oral

1.3

70.8

6080

37474

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

70.3

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

70.3

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

4.9

70.2

169

264

WPA11

NOMESCO Finland

Developing a plan for palliative care

10.1

70.2

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.9

70.1

JEA00

NOMESCO Finland

Appendectomy

1.9

70.0

925

3748

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

29.1

69.8

GDC00

NOMESCO Finland

Lobectomy of lung

14.0

69.7

K56.0

ICD-10 Finland

Paralytic ileus

3.5

69.6

257

561

191

Kela drug reimbursment

Erlotinib

+∞

69.4

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

69.4

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

69.4

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

69.4

WPA13, ,

SPAT

15.6

69.3

L03

ICPC

Low back symptom/complaint

0.7

69.0

3066

31616

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

68.4

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

68.4

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

68.4

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

68.4

SFA20

NOMESCO Finland

Two-surface restoration

0.8

68.4

7435

67013

K92.0

ICD-10 Finland

Haematemesis

2.3

68.2

546

1823

DAB10

NOMESCO Finland

Partial excision of auricle

28.6

68.2

JDW97

NOMESCO Finland

Other laparoscopic operation on stomach or duodenum

28.6

68.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

68.1

3902

22536

D82

ICPC

Teeth/gum disease

0.7

68.0

3833

37995

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

67.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

67.5

L02BB04

ATC

enzalutamide; oral

+∞

67.5

197

Kela drug reimbursment

Sunitinib

+∞

67.5

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.8

67.5

373

1040

KCD10

NOMESCO Finland

Partial cystectomy

33.8

67.4

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

13.5

67.4

B82

ICPC

Anaemia other/unspecified

2.2

67.4

601

2102

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

67.3

905

3688

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

67.2

2922

30265

A10AE04

ATC

insulin glargine; parenteral

1.6

67.0

1966

9949

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

9.3

67.0

R4110, ,

SPAT

0.6

66.9

1230

15294

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

66.6

N03AX16

ATC

[U] pregabalin

1.4

66.4

4136

24210

A21

ICPC

Risk factor for malignancy

24.3

66.1

C82.1

ICD-10 Finland

Follicular lymphoma grade II

282.3

66.0

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

19.0

65.9

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

17.5

65.8

Z2446

NOMESCO Finland

Social worker

1.9

65.7

950

3966

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

65.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

65.6

3019

Kela drug reimbursment

Lenvatinib

+∞

65.6

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.3

65.6

185

331

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

65.4

1683

8258

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

13.0

65.2

G04CA02

ATC

tamsulosin; oral

1.3

65.2

4966

29990

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

278.5

65.1

L08

ICPC

Shoulder symptom/complaint

0.7

64.7

2484

26347

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

64.7

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

64.7

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

64.2

882

3620

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

64.1

397

1175

B80

ICPC

Iron deficiency anaemia

2.4

63.9

483

1572

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

17.6

63.9

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

63.9

1106

4880

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

186.6

63.7

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

+∞

63.7

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

63.7

1508

Kela drug reimbursment

Lenvatinib

+∞

63.7

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

63.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

68.2

63.7

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

115.1

63.2

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

6.7

63.0

112

129

KAC10

NOMESCO Finland

Total nephrectomy with capsule

12.2

62.9

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

62.8

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

62.8

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

62.8

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

62.8

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

62.7

2770

28670

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.8

62.6

126

166

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.4

62.5

465

1503

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.4

62.4

247

565

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

5.7

62.3

128

172

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

25.4

62.3

SPAT1290

SPAT

Preparation of deceased person

11.9

62.1

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

83.3

62.0

C10AA05

ATC

atorvastatin; oral

0.8

61.9

6733

60979

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

61.7

249

577

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

61.7

2314

12334

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.3

61.7

172

305

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.9

61.2

105

116

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

61.2

2630

27371

R83

ICPC

Respiratory infection other

0.6

61.2

1706

19300

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

512.9

61.0

R03AC02

ATC

salbutamol; inhalant

0.8

61.0

7270

65135

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

178.9

61.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

60.9

L01EX08

ATC

lenvatinib; oral

+∞

60.9

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

60.9

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

60.8

2896

29613

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

259.1

60.5

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

110.4

60.5

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

12.2

60.4

R01AD12

ATC

fluticasone furoate; nasal

0.7

60.1

2788

28645

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

60.0

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

60.0

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

60.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

59.6

1243

5775

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

9.2

59.6

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

9.8

59.6

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

59.5

230

518

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.6

59.5

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

59.4

334

940

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.6

59.4

209

442

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.1

59.3

176

328

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

497.5

59.2

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

59.0

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

59.0

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

59.0

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

59.0

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

59.0

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

6.7

59.0

105

121

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

13.0

58.9

C209, 8211, 2

ICD-O-3

14.2

58.9

LEC00

NOMESCO Finland

Partial excision of vagina

21.4

58.8

JFH10

NOMESCO Finland

Total colectomy and ileostomy

7.8

58.6

N02AA03

ATC

hydromorphone; systemic, rectal

8.7

58.5

KAD00

NOMESCO Finland

Partial nephrectomy

10.0

58.4

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

19.7

58.2

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

8.2

58.2

8070/3-C15.5

ICD-O-3

Squamous cell carcinoma, NOS, of lower third of esophagus

+∞

58.1

316

Kela drug reimbursment

Imatinib

+∞

58.1

L01BC04

ATC

carmofur; oral

+∞

58.1

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

5.6

58.1

121

165

ZXC40

NOMESCO Finland

Use of ultrasound

5.6

58.1

121

165

TJF00

NOMESCO Finland

Insertion of jejunal tube

23.0

58.1

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

20.3

57.8

G47.3

ICD-10 Finland

Sleep apnoea

0.7

57.6

2586

26751

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

8.2

57.6

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.8

57.4

193

395

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

482.1

57.3

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

482.1

57.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

57.2

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

57.2

SFA10

NOMESCO Finland

One-surface restoration

0.8

57.2

7049

63083

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.7

57.1

3865

37468

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

9.7

57.1

C187, 8148, 2

ICD-O-3

12.9

57.0

ZX100

NOMESCO Finland

Oral

3.2

57.0

250

611

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

56.8

3065

30764

XF612

NOMESCO Finland

Measurement of central venous pressure

7.9

56.7

TJG20

NOMESCO Finland

Transanal irrigation

8.6

56.7

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.0

56.5

G04BE03

ATC

sildenafil; oral

4.3

56.5

158

281

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

166.1

56.4

R01AD09

ATC

mometasone; nasal

0.8

56.3

5228

48523

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

56.2

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

56.2

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

+∞

56.2

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.0

56.1

173

332

KA3EB

NOMESCO Finland

Antegrade pyelography

6.6

56.1

101

118

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.5

56.1

205

445

A04AA03

ATC

tropisetron; systemic

33.7

55.9

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.7

55.6

141

231

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.0

55.5

262

669

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

466.7

55.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

466.7

55.4

C16.21

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

+∞

55.3

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

55.3

8140/3-C16.3

ICD-O-3

Adenocarcinoma, NOS, of gastric antrum

+∞

55.3

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

11.5

55.1

R74

ICPC

Upper respiratory infection acute

0.7

54.8

2647

27077

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

54.8

1120

5175

WPA16, ,

SPAT

23.0

54.6

OAB48, ,

SPAT

0.5

54.6

657

9211

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

459.0

54.5

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

7.7

54.4

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

54.4

1321

6380

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.3

54.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

54.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

54.4

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

54.4

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

16.6

54.2

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

8.8

54.1

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

158.4

53.6

L02BX03

ATC

abiraterone; oral

451.3

53.6

TKE10

NOMESCO Finland

Puncture of prostate

21.6

53.5

K31.5

ICD-10 Finland

Obstruction of duodenum

10.2

53.4

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

53.4

8480/3-C16.9

ICD-O-3

Mucinous adenocarcinoma of stomach, NOS

+∞

53.4

8070/3-C21.1

ICD-O-3

Squamous cell carcinoma, NOS, of anal canal

+∞

53.4

L13

ICPC

Hip symptom/complaint

0.7

53.1

2163

22801

D19

ICPC

Teeth/gum symptom/complaint

0.7

53.0

3101

30788

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.3

52.6

150

271

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.1

52.5

121

182

1CD02, ,

NOMESCO Finland

+∞

52.5

8145/3-C16.0

ICD-O-3

Carcinoma, diffuse type of cardia, NOS

+∞

52.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

52.5

8000/3-C18.9

ICD-O-3

Neoplasm, malignant of colon, NOS

+∞

52.5

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

52.5

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

5.3

52.4

116

168

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

96.6

52.3

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

10.5

52.3

JFA42

NOMESCO Finland

Endoscopic injection in colon

4.8

52.1

128

204

OAA80, ,

SPAT

0.4

52.0

288

5321

ZZR10

NOMESCO Finland

Flap of skin and muscle

7.8

51.8

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.4

51.6

140

243

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

10.3

51.6

8249/3-C17.2

ICD-O-3

Neuroendocrine tumor, grade 2 of ileum

+∞

51.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

51.5

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

51.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

51.3

6615

42614

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

51.1

556

8046

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

428.2

50.8

FM1FN

NOMESCO Finland

Heart function isotope examination

428.2

50.8

JDC11

NOMESCO Finland

Laparoscopic partial gastrectomy and gastrojejunostomy

115.0

50.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

50.6

2997

17307

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

50.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

50.6

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

50.6

C15.2

ICD-10 Finland

Malignant neoplasm: Abdominal part of oesophagus

+∞

50.6

L03AB05

ATC

interferon alfa-2b; parenteral

219.5

50.3

JFA73

NOMESCO Finland

Excision of lesion of small intestine

13.6

50.3

M54.5

ICD-10 Finland

Low back pain

0.8

50.3

4290

40417

S18

ICPC

Laceration/cut

1.3

50.2

8407

55801

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.8

50.2

5297

48569

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1666

1146

11.98

307.65

3.5

2.1

2361.75

10.42

u/ml

2.85

1653

1135

(40768441) Liver Pathology biopsy report

949

497

15.24

307.65

1.4

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6345

21086

2.86

307.65

5.1

2.6

0.79

0.82

mmol/l

65.52

6113

19437

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3005

7895

3.23

307.65

9.8

10.5

15.60

16.13

19.97

2928

7640

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8669

29720

3.09

307.65

3.4

2.2

—

(3033658) Prothrombin time (PT) actual/Normal

8679

32208

2.81

307.65

6.8

3.8

84.55

86.71

12.53

8581

31437

(3003694) ABO and Rh group [Type] in Blood

7105

32462

2.02

307.65

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

13989

7168

42.70

307.65

8.3

1.5

39.62

6.72

ug/l

8.32

12810

5419

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

818

666

9.73

307.65

2.3

1.4

21.93

19.01

ug/l

0.87

804

644

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4218

13907

2.65

307.65

9.5

8.7

115.14

122.74

g/l

108.99

4131

13619

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6569

10848

6.28

307.65

3.1

2.1

0.20

g/l

8.17

6314

9872

(3024561) Albumin [Mass/volume] in Serum or Plasma

14478

60464

3.67

307.65

10.9

4.1

32.88

35.65

g/l

307.65

14083

55756

(3021162) Amylase [Enzymatic activity/volume] in Specimen

350

30.21

307.65

2.8

2.4

985.87

2992.34

u/l

0.56

315

(3022145) Colonoscopy Study observation

6071

14595

4.07

307.65

1.6

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

5799

2774

21.69

307.65

5.8

2.0

3682.56

93.37

u/ml

2.90

5303

2277

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1069

503

17.06

307.65

6.5

1.3

204.60

82.70

nmol/l

10.39

1061

494

(3019977) pH of Arterial blood

4727

16964

2.46

307.65

8.9

7.8

7.41

7.42

8.05

2256

9711

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4404

11927

3.31

307.65

3.9

2.3

48.54

46.42

u/l

0.09

3937

9980

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13403

57121

3.19

307.65

4.0

2.5

—

estimate

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7962

36734

2.06

307.65

2.5

2.4

3.46

2.81

mg/l

61.33

7065

31481

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10339

43847

2.58

307.65

4.0

2.4

71.47

61.51

u/l

0.76

9948

40191

(3002256) Pathology report gross observation

4206

10459

3.59

307.65

1.4

1.1

—

(3000991) Gas panel - Venous blood

3528

12099

2.48

307.65

9.6

9.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

14279

81843

2.04

307.65

7.8

4.9

7.08

6.85

mmol/l

29.04

13931

77671

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6538

27053

2.23

307.65

7.8

2.2

2.48

2.45

mmol/l

88.07

6213

23719

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

16671

101996

2.21

307.65

19.5

6.0

115.18

76.50

u/l

307.65

16320

95219

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11929

62579

2.06

307.65

8.7

6.1

1.19

1.21

mmol/l

103.16

11361

56904

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1884

4240

3.63

307.65

1.5

1.4

188.74

281.54

ug/g

62.07

1191

2527

(3016502) Oxygen saturation in Arterial blood

4423

15211

2.55

307.65

9.1

8.1

96.61

95.02

49.94

4307

14695

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3672

13205

2.36

307.65

3.7

2.3

251.37

235.79

u/l

2.99

3512

12231

(3023368) Bacteria identified in Blood by Culture

9904

38082

2.87

307.65

5.6

4.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6121

22316

2.55

307.65

2.4

2.7

2.35

2.30

g/l

7.81

5843

20352

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2942

9380

2.63

307.65

10.3

10.0

1.24

1.36

9.75

2933

9314

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4599

17835

2.24

307.65

5.3

5.9

1.00

1.04

mmol/l

10.02

4372

16402

(3022948) Iron [Moles/volume] in Serum or Plasma

6449

23955

2.53

307.65

2.5

2.7

10.98

12.77

umol/l

58.01

6182

21994

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

13023

70208

2.10

307.65

9.6

6.5

1.19

1.21

mmol/l

133.09

11387

60151

(3015377) Calcium [Moles/volume] in Serum or Plasma

9456

44332

2.15

307.65

8.0

2.2

2.34

2.35

mmol/l

23.23

8976

38934

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5831

20612

2.61

307.65

2.4

2.8

19.11

22.35

51.87

5606

18902

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

805

653

9.76

307.65

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3509

1613

19.76

307.65

5.4

2.0

1780.81

25.51

u/ml

9.65

3233

1445

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1900

4313

3.60

307.65

2.6

3.2

0.31

0.35

iu/ml

6.33

974

2470

(3044640) Blood type and Crossmatch panel - Blood

10749

38957

3.27

307.65

3.6

2.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1653

673

20.29

307.65

5.7

1.7

15.03

4.21

nmol/l

1.63

1631

639

(40768804) Tissue Pathology biopsy report

9757

41480

2.49

307.65

2.7

1.7

—

(4035726) Immunohistochemistry procedure

5167

3552

14.42

307.65

1.5

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2899

9011

2.69

307.65

10.4

0.63

0.64

1.27

2889

8957

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5760

14178

3.90

307.65

4.6

2.2

17.59

7.63

umol/l

55.45

5324

12323

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2621

8416

2.58

307.65

10.5

9.9

23.96

24.39

mmol/l

9.53

2598

8157

(3014111) Lactate [Moles/volume] in Serum or Plasma

3740

12687

2.52

307.65

8.5

7.8

1.31

1.40

mmol/l

4.53

3682

12409

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8873

42800

2.01

307.65

5.7

2.8

44.37

34.71

u/l

9.20

8560

39887

(3003396) Base excess in Arterial blood by calculation

4655

16885

2.42

307.65

8.9

7.7

0.57

1.14

mmol/l

18.43

4024

13908

(3020779) Urea [Moles/volume] in Serum or Plasma

3726

12699

2.51

307.65

6.4

7.5

9.05

10.95

mmol/l

40.99

3582

12066

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3180

9744

2.76

307.65

1.7

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2795

8737

2.67

307.65

8.9

8.6

24.60

24.86

mmol/l

3.15

2781

8658

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15441

66978

3.88

307.65

17.5

4.0

15.31

12.02

umol/l

39.90

15173

62948

(3042936) Bacteria identified in Isolate by Culture

4738

18967

2.17

307.65

2.2

2.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

4702

16973

2.44

307.65

8.9

7.8

13.86

11.59

kpa

133.27

4570

16295

(3013650) Neutrophils [#/volume] in Blood by Automated count

14076

70399

2.60

307.65

18.1

6.7

4.18

4.32

e9/l

7.24

12445

59521

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

397

153

20.20

307.65

2.4

1.1

21.98

14.65

u/ml

4.28

380

137

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4701

16983

2.44

307.65

9.0

7.8

5.14

5.06

kpa

7.17

4575

16314

(3032080) INR in Blood by Coagulation assay

14121

67095

2.86

307.65

15.3

17.7

1.24

1.32

inr

68.40

11990

56287

(3030467) Casts [#/volume] in Urine by Automated count

7579

38861

1.77

300.50

3.6

3.2

0.71

0.46

e6/l

5.96

5752

28438

(40768797) Stomach Pathology biopsy report

4439

19284

1.96

296.99

1.6

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14872

130903

0.55

295.42

4.8

5.6

4.41

4.53

mmol/l

38.82

13453

121931

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14735

130031

0.55

295.22

4.8

5.5

1.41

1.45

mmol/l

25.91

13207

120259

(3018418) pH of Serum or Plasma

7911

41313

1.74

292.12

5.2

3.6

7.40

0.19

5642

29304

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1825

5480

2.69

292.04

2.1

1.9

2.14

2.07

ug/l

0.10

1658

4786

(3002582) Erythrocytes [#/volume] in Urine

8489

45335

1.72

288.36

3.8

3.3

66.94

84.45

e6/l

0.80

6633

34543

(3037121) Protein [Mass/volume] in Urine

1577

4433

2.86

285.28

5.4

2.9

349.27

597.25

mg/l

1.14

1141

1663

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5136

23768

1.86

281.99

2.0

1.9

—

(36304419) Bacteria [Presence] in Urine

7118

36362

1.75

281.31

3.6

3.1

0.28

75.79

estimate

0.63

204

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15324

133192

0.55

273.10

5.5

6.5

2.52

2.61

mmol/l

30.49

13774

123689

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5281

60002

0.56

263.57

2.0

1.39

1.34

mmol/l

3.18

4369

49466

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

269

133

15.65

262.41

1.3

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1214

3094

3.12

259.70

3.1

2.6

37.23

32.87

umol/l

6.15

1117

2765

(3019069) Monocytes/Leukocytes in Blood

10483

60384

1.65

257.91

6.1

6.0

9.27

9.03

10.20

9893

55966

(3006504) Eosinophils/Leukocytes in Blood

10454

60251

1.65

255.82

6.0

5.9

2.60

2.97

46.47

9874

55821

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

221

23.70

254.28

3.6

2.2

90.85

62.53

pmol/l

0.96

189

(40768795) Lymph node Pathology biopsy report

299

199

11.64

249.62

1.2

1.1

—

(3002030) Lymphocytes/Leukocytes in Blood

10592

61587

1.63

246.81

6.1

5.9

23.28

27.13

205.99

10087

57812

(3022096) Basophils/Leukocytes in Blood

10425

60408

1.63

245.95

6.1

6.0

0.60

0.68

39.25

9836

55968

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1332

3751

2.83

239.06

2.6

1.5

93.43

23.98

u/ml

8.78

1292

3559

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4605

21561

1.81

237.42

2.2

2.0

30.15

29.78

3.00

4519

20943

(4281824) Cell count and differential, peritoneal fluid

477

631

5.89

235.45

1.2

—

(3026782) Osmolality of Urine

5343

26243

1.75

233.49

3.3

2.9

532.07

531.70

mosm/kgh2o

0.04

4854

22786

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1177

3174

2.94

228.06

2.5

3.53

3.62

g/l

0.98

1143

3023

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4617

21908

1.78

226.11

3.4

3.0

2.68

2.72

e6/l

0.07

2384

10572

(3018010) Neutrophils/Leukocytes in Blood

10323

60531

1.60

223.55

5.9

60.59

57.75

88.45

9904

57324

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

270

183

11.41

222.97

2.8

2.2

1360.83

15.15

ug/l

1.92

270

183

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14258

124552

0.61

212.44

4.2

4.7

1.33

1.30

mmol/l

4.25

12677

113901

(3018095) Leukocytes [#/volume] in Urine

8917

50903

1.59

212.40

4.5

3.9

130.73

117.40

e6/l

0.44

6735

35826

(3027945) Reticulocytes/Erythrocytes in Blood

3656

16443

1.85

211.72

2.2

2.1

1.83

1.77

2.50

3294

14356

(3031040) Bacteria [#/volume] in Urine by Automated count

13765

87774

1.58

194.66

5.2

4.8

1710.39

1949.02

e6/l

0.18

215

1368

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14880

128100

0.62

194.63

7.4

7.2

41.23

40.18

mmol/mol

30.23

13659

119220

(3006315) Basophils [#/volume] in Blood

10977

66675

1.54

191.28

5.8

0.04

e9/l

20.87

9190

56485

(3001604) Monocytes [#/volume] in Blood

10936

66395

1.54

190.75

5.8

5.7

0.63

0.61

e9/l

15.61

9147

56262

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3825

17944

1.77

190.53

1.9

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

11117

67898

1.53

187.15

6.0

5.8

1.66

1.84

e9/l

18.06

9566

58925

(40758558) Short blood count panel - Blood

6972

38626

1.57

180.41

12.8

4.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

336

410

6.35

178.96

1.7

2.4

4110.50

2159.17

e6/l

0.37

230

283

(3013115) Eosinophils [#/volume] in Blood

11155

68607

1.52

177.78

6.1

5.9

0.18

0.20

e9/l

33.08

9503

59064

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9823

58820

1.52

177.51

3.3

3.1

148.61

133.50

ug/l

3.89

9170

54151

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3584

16812

1.76

177.15

1.9

1.8

—

(40768800) Prostate Pathology biopsy report

435

723

4.67

168.15

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

726

1778

3.20

164.78

1.2

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4752

24562

1.62

161.27

3.3

2.9

1.25

1.12

e6/l

1.40

2531

13272

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1276

4263

2.37

160.75

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1080

3340

2.55

160.40

2.4

2.2

82.46

90.98

21.05

1068

3201

(3000850) Epithelial cells [#/volume] in Urine

5788

31384

1.57

160.30

2.9

2.7

5.89

4.99

e6/l

4.78

5359

28481

(3012544) pH of Venous blood

3283

15578

1.72

153.60

3.8

3.9

7.38

0.95

1967

9024

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1142

3718

2.43

152.08

1.8

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

2791

12679

1.79

151.73

2.3

2.1

69.68

68.63

e9/l

0.68

2057

9421

(3002032) Base excess in Venous blood by calculation

3168

14933

1.73

151.58

3.8

3.9

1.81

1.83

mmol/l

0.14

2680

13183

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3228

15340

1.72

149.86

3.8

5.66

5.84

kpa

19.16

3152

14977

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2251

9604

1.89

149.50

8.1

6.9

24.36

24.55

mmol/l

1.50

2155

9256

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15348

129556

0.65

147.16

5.4

5.7

6.25

6.07

mmol/l

47.95

13922

118441

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1002

3125

2.52

146.03

2.4

2.5

227.64

195.79

18.74

965

2937

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

278

346

6.21

145.38

1.7

2.2

13231.93

14436.01

e6/l

0.05

151

176

(3007930) Methemoglobin/Hemoglobin.total in Blood

1619

6260

2.06

142.25

6.7

4.9

0.87

0.23

1530

5949

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2569

11721

1.77

136.55

1.5

—

(3039000) Anion gap in Blood by calculation

926

2894

2.51

134.20

8.5

6.6

11.02

11.41

mmol/l

3.31

845

2632

(3018572) Chloride [Moles/volume] in Blood

926

2895

2.51

134.11

8.5

6.6

105.95

104.71

mmol/l

12.10

845

2633

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14431

122678

0.68

131.11

5.0

5.3

2.06

1.99

mu/l

7.05

12965

112471

(3044007) Cell count panel - Peritoneal fluid

267

355

5.81

131.07

1.7

2.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1699

6889

1.96

130.40

6.5

4.7

1.60

1.61

0.05

1608

6564

(3047181) Lactate [Moles/volume] in Blood

1203

4298

2.21

128.99

7.4

5.7

1.46

1.35

mmol/l

2.21

1073

3830

(3019060) Gas panel - Arterial blood

2111

9256

1.83

127.52

6.1

4.7

—

(1761868) Lipid panel - Serum or Plasma

4468

46826

0.66

125.41

3.3

3.5

—

(3004809) Band form neutrophils/Leukocytes in Blood

604

1578

2.98

122.81

2.7

2.3

2.33

1.26

6.64

546

1364

(3010370) Gastrin [Moles/volume] in Serum or Plasma

170

143

9.15

122.15

2.7

1.6

73.18

49.79

pmol/l

0.91

139

122

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

665

1879

2.76

117.42

6.0

6.1

11.97

12.10

mg/l

0.29

604

1729

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11695

102233

0.72

111.83

4.1

4.3

15.00

14.94

pmol/l

1.85

10497

92857

(3045142) Bone marrow Pathology biopsy report

313

559

4.33

110.98

1.3

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

665

1978

2.62

106.31

5.5

6.1

812.95

794.72

iu/ml

0.02

111

295

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

607

1745

2.71

103.67

1.2

1.1

1.65

1.53

g/l

8.37

571

1577

(3017143) Hepatitis C virus Ab [Presence] in Serum

2237

10554

1.69

103.65

1.4

1.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

252

399

4.87

103.00

2.0

1.5

1.87

2.00

umol/l

1.38

237

360

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1880

8491

1.76

101.70

3.8

4.0

24.07

24.25

mmol/l

1.27

1855

8367

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2756

13814

1.60

100.53

4.9

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2225

10626

1.67

98.16

4.9

3.2

1.22

1.23

mmol/l

4.68

2038

8851

(3036489) Thrombin time

1151

4501

2.01

97.01

2.2

2.0

21.54

21.37

0.38

1091

3972

(3007566) Smooth muscle Ab [Titer] in Serum

965

3635

2.08

89.88

1.3

1.2

96.00

137.12

titre

0.84

326

(40768793) Breast Pathology biopsy report

329

714

3.56

89.81

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2172

25084

0.62

89.55

1.3

41.63

38.93

iu/ml

0.30

682

7774

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1983

23383

0.61

89.40

1.3

15.98

13.48

u/ml

0.41

711

8741

(3024354) Oxygen [Partial pressure] in Venous blood

2576

13053

1.58

88.90

3.4

3.2

4.49

4.48

kpa

0.03

2506

12713

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

86.25

1.1

0.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1497

6675

1.77

83.98

1.5

1.6

1.70

1.58

g/l

4.65

1298

5693

(3034770) Mitochondria Ab [Titer] in Serum

945

3625

2.04

83.75

1.3

1.2

515.83

1070.26

titre

2.35

114

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

252

478

4.07

82.85

2.0

1.4

27.15

28.98

umol/l

1.84

245

446

(3018405) Lactate [Moles/volume] in Arterial blood

1195

5016

1.87

81.53

4.6

4.2

1.43

1.41

mmol/l

0.17

1173

4910

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

506

1511

2.60

80.19

2.4

2.8

3030.38

7170.35

u/ml

0.27

(3026692) Albumin [Mass/volume] in Peritoneal fluid

204

336

4.68

79.78

1.4

1.6

13.28

12.68

g/l

0.37

165

235

(3042111) Morphology [Interpretation] in Bone marrow Narrative

422

1153

2.83

79.21

1.5

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

526

1624

2.51

77.90

1.4

1.5

31.94

48.78

g/l

0.42

478

1427

(3002331) Protein [Mass/volume] in Peritoneal fluid

177

266

5.12

76.71

1.2

1.6

34.10

45.86

g/l

0.21

134

202

(40768806) Pleura Pathology biopsy report

401

1095

2.83

75.36

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

2227

11336

1.56

74.45

3.6

3.7

1.08

0.71

8.81

1002

2429

(3023199) Leukocytes [#/volume] in Pleural fluid

476

1448

2.55

72.67

1.4

2244.27

3434.86

e6/l

0.67

338

1030

(3028308) Erythrocytes [#/volume] in Pleural fluid

430

1277

2.61

68.91

1.4

1.5

69764.92

58780.74

e6/l

0.20

255

728

(3037467) Urinalysis macro (dipstick) panel - Urine

13430

92541

1.30

67.17

5.5

4.7

1.79

87.67

0.50

156

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1184

5262

1.76

66.76

2.0

1.9

—

(3045788) Cell count panel - Pleural fluid

400

1165

2.66

66.62

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1938

9793

1.56

66.48

3.3

120.26

130.79

g/l

69.26

1892

9527

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

736

2840

2.02

64.02

1.5

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

2094

10852

1.53

63.99

3.4

3.6

0.81

0.55

4.87

927

2400

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1395

6618

1.65

61.88

1.3

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1092

4859

1.76

61.21

1.9

1.8

—

(3012501) Base excess in Blood by calculation

722

2821

1.99

60.64

4.5

4.1

2.80

2.59

mmol/l

1.08

527

1912

(3013290) Carbon dioxide [Partial pressure] in Blood

722

2823

1.99

60.52

4.5

4.1

4.96

5.02

kpa

1.04

710

2746

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

763

10507

0.54

59.95

2.0

2.1

3.51

3.49

ratio

0.10

643

8465

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12287

84272

1.28

59.75

5.0

3.2

109.95

48.78

u/l

168.69

11671

77989

(3021440) Promyelocytes/Leukocytes in Blood

2095

11016

1.50

59.54

3.6

3.8

0.14

0.06

6.40

880

2121

(3027315) Oxygen [Partial pressure] in Blood

723

2845

1.98

59.52

4.5

4.1

8.94

8.42

kpa

7.69

711

2767

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

9.81

58.96

1.9

1.2

20.39

14.15

pmol/l

0.86

(3025941) Bacteria identified in Stool by Culture

1362

6503

1.64

58.84

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.76

58.73

6.9

1.2

34.85

88.56

ug/l

1.08

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

483

1650

2.27

57.26

1.4

139.08

76.39

pmol/l

2.73

476

1611

(3021589) Normoblasts [#/volume] in Blood

8839

58428

1.27

57.24

19.2

10.4

0.00

e9/l

2.48

7013

47601

(3010813) Leukocytes [#/volume] in Blood

17564

140556

0.73

56.67

51.1

23.3

7.10

6.73

e9/l

60.32

17160

136231

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

472

7448

0.47

56.49

1.7

1.8

3.34

3.43

mmol/l

0.97

353

5342

(3000963) Hemoglobin [Mass/volume] in Blood

17565

140553

0.73

56.48

51.5

23.5

124.23

136.24

g/l

307.65

17374

138574

(3026361) Erythrocytes [#/volume] in Blood

17564

140539

0.73

56.33

51.0

23.3

4.20

4.50

e12/l

307.65

17154

136212

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

17563

140532

0.73

56.33

52.5

23.8

37.58

40.79

209.59

17354

138471

(3024731) MCV [Entitic mean volume] in Red Blood Cells

17564

140533

0.73

56.22

50.9

23.2

91.26

91.51

9.22

17375

138525

(3035941) MCH [Entitic mass]

17563

140524

0.73

56.17

50.9

23.2

30.08

30.46

113.22

17370

138519

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

7.43

56.13

2.0

2.9

54.66

58.37

0.28

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

745

3026

1.91

55.91

1.5

1.4

—

(3007461) Platelets [#/volume] in Blood

17562

140496

0.73

55.76

51.1

23.3

250.41

243.70

e9/l

25.24

17214

136837

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

897

3885

1.80

55.01

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

318

3.99

53.27

3.3

2.3

1.60

1.01

2.64

165

318

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

185

389

3.66

53.02

2.9

2.3

0.60

0.61

mmol/l

1.65

185

389

(3019225) pH of Specimen

2449

13574

1.43

52.68

4.6

3.8

7.37

7.36

2.49

2048

9018

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

542

2024

2.07

51.49

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

741

3090

1.86

51.30

1.5

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

356

1116

2.46

51.14

2.6

2.3

61.30

61.12

0.05

300

934

(3010421) pH of Blood

957

4314

1.73

51.13

4.1

3.6

7.41

1.34

947

4245

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1618

8361

1.52

49.52

3.0

2.9

1.19

1.20

0.11

1608

8329

(3025159) Blasts/Leukocytes in Blood

2056

11153

1.45

49.46

3.7

4.0

0.12

0.03

0.76

808

2021

(3043410) Blood group antigens tested for on Red Blood Cells

150

289

3.99

48.49

2.1

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1430

7236

1.55

48.14

3.6

3.4

24.69

25.33

mmol/l

8.26

1382

7008

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1596

8282

1.51

47.83

2.9

2.8

0.65

0.62

3.20

1588

8261

(3036782) Glucose [Moles/volume] in Pleural fluid

345

1108

2.40

47.08

1.3

6.27

6.63

mmol/l

1.38

322

1019

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

334

1066

2.42

46.21

1.3

689.06

398.92

u/l

0.64

316

990

(1616796) Gas panel - Central venous blood

719

3084

1.81

45.48

3.6

3.9

—

(40761536) Microorganisms panel - Urine sediment

1834

9891

1.46

45.29

4.6

4.1

—

(3020891) Body temperature

1430

7360

1.52

44.44

5.2

4.6

36.87

36.91

°c

2.04

1422

7293

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4706

29500

1.28

44.04

3.9

4.2

401.79

548.65

ng/l

1.12

3978

24462

(21494755) Public health laboratory ask at order entry panel

613

8177

0.56

42.54

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

244

703

2.67

41.65

2.2

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

314

1031

2.35

40.87

2.7

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

4356

27258

1.28

40.84

1.8

1177.76

1158.86

nmol/l

0.61

3363

20573

(3052851) Hemolysis interference index of Serum or Plasma

809

3719

1.69

40.18

4.4

3.4

2.21

1.68

index

1.84

492

1781

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7357

48990

1.23

39.55

3.0

3.3

1487.33

1520.03

ng/l

0.25

6520

42345

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

578

2446

1.83

38.21

1.5

—

(3000012) Reticulocyte production index

477

1900

1.94

37.95

2.0

1.7

0.86

0.90

0.68

366

1236

(3005719) IgG [Mass/volume] in Serum or Plasma

1657

9062

1.43

37.70

2.6

2.4

10.78

10.82

g/l

0.13

1518

8314

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

6.51

37.64

1.8

3.0

24.53

17.13

0.64

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

7.00

37.10

1.6

1.2

2058.39

157.82

u/l

0.96

(3049717) Cytology report of Urine Cyto stain

954

4666

1.59

37.06

2.8

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

6580

43528

1.23

37.03

1.9

1.7

20.44

20.25

nmol/l

0.41

5816

36376

(3020564) Creatinine [Moles/volume] in Serum or Plasma

17537

139233

0.77

36.94

44.6

20.5

80.72

80.85

umol/l

0.16

17333

137242

(3025468) Yersinia sp identified in Specimen by Organism specific culture

412

1577

2.02

36.71

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

412

1583

2.01

36.33

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

440

1731

1.96

36.30

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

413

1589

2.01

36.28

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

431

1686

1.97

36.14

1.5

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

551

2344

1.82

35.82

3.5

3.0

58.77

58.64

0.08

551

2344

(3024522) Salmonella sp identified in Specimen by Organism specific culture

429

1684

1.97

35.63

1.5

1.3

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13044

106708

0.83

35.37

44.8

20.2

329.16

332.28

g/l

253.27

12957

106088

(40760892) CBC W Ordered Manual Differential panel - Blood

4277

27124

1.26

35.06

4.6

4.3

—

(40767503) Oxygen content in Capillary blood by calculation

649

2927

1.72

34.57

2.6

2.7

15.07

16.65

27.19

642

2866

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

393

1512

2.01

34.55

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

177

484

2.81

33.43

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

759

3608

1.63

33.13

4.5

2.9

1.69

1.72

mg/l

0.28

694

3176

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

897

4454

1.56

32.64

2.4

2.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1324

7135

1.45

32.48

1.9

1.5

1.37

1.19

g/l

1.46

1217

6528

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

250

824

2.33

32.36

1.3

13.95

12.60

u/l

0.34

222

743

(3001893) Eosinophils/Leukocytes in Pleural fluid

134

318

3.24

32.22

1.4

2.53

2.87

0.16

111

261

(1002224) Polysomnography panel

381

5382

0.53

32.12

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

148

376

3.02

31.84

1.3

1.4

57.15

63.99

1.33

123

297

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

171

472

2.78

31.77

1.6

1.5

4.08

3.83

mg/l

0.34

163

450

(3043409) Potassium [Moles/volume] in Arterial blood

862

4274

1.56

31.56

4.9

4.6

3.83

3.90

mmol/l

4.81

855

4238

(3012516) Albumin [Mass/volume] in Urine

6226

54110

0.83

31.12

3.5

3.6

61.74

45.30

mg/l

5.00

4243

34583

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

384

1526

1.94

30.84

1.5

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

239

790

2.33

30.77

1.1

—

0.62

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

264

915

2.22

30.44

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

497

2159

1.78

30.20

1.9

1.79

1.73

mmol/l

0.60

490

2104

(3035880) pH of Pleural fluid

199

610

2.51

30.17

1.2

1.3

7.41

0.15

141

424

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8394

57653

1.19

29.76

4.2

4.1

44.71

76.98

ng/l

3.15

6922

42874

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

436

1830

1.84

29.66

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

725

3503

1.60

29.63

3.7

3.1

8.06

7.99

kpa

0.49

706

3424

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1909

11108

1.34

29.62

4.3

2.5

65.52

62.88

ml/min/173m2

2.02

883

4503

(3020630) Protein [Mass/volume] in Serum or Plasma

2060

12143

1.33

29.26

2.5

1.6

64.33

66.64

g/l

27.91

1870

10938

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

465

2000

1.79

29.23

1.4

1.5

—

(3024928) Oxygen saturation in Venous blood

778

3837

1.57

29.16

2.7

3.2

60.48

61.74

0.77

754

3685

(3016650) Hepatitis A virus Ab [Presence] in Serum

423

1769

1.84

29.12

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

244

834

2.25

29.10

2.7

1.9

8.04

8.23

mmol/l

0.30

244

834

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

601

2790

1.67

28.80

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

601

2790

1.67

28.80

1.3

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1447

8092

1.39

28.77

4.4

3.9

46.09

47.43

1.26

1432

7989

(40765096) Chromosome analysis panel by Banding

119

4.64

28.30

1.2

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

178

3123

0.43

28.24

1.2

1.55

1.51

g/l

1.25

178

3123

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

421

1777

1.83

28.15

1.3

1.5

160.40

154.83

au/ml

0.41

108

574

(21494434) Karyotype in Bone marrow

200

638

2.41

27.91

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

167

491

2.61

27.59

1.8

1.9

17.26

16.17

0.50

162

473

(3009508) Creatinine [Moles/volume] in Urine

6428

55285

0.84

27.50

3.5

7.24

7.47

mmol/l

4.45

5313

46526

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

731

8427

0.65

27.40

1.2

1.3

50.71

55.00

au/ml

0.23

572

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

17348

137206

0.81

27.35

23.7

11.0

28.86

26.02

u/l

32.94

17053

132133

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

156

2845

0.41

27.29

1.1

0.64

0.63

ratio

0.10

482

(1175426) CD3 cells/Lymphocytes in Blood

172

518

2.55

27.09

1.9

2.0

70.95

72.46

0.53

166

490

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1698

9839

1.35

26.99

3.7

3.6

5.04

5.17

kpa

7.68

1601

9330

(3009343) pH of Capillary blood

1653

9548

1.35

26.82

3.7

3.6

7.42

0.20

1393

7951

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1467

8321

1.37

26.72

3.5

2.02

1.88

mmol/l

0.59

1040

6144

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

821

9197

0.67

26.68

2.3

2.5

28.77

23.61

au/ml

0.51

841

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

295

1130

2.01

26.36

2.9

2.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

263

968

2.09

26.17

1.5

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

112

276

3.11

25.45

1.2

1.3

537.40

10.11

ug/l

1.37

125

(3000919) Neutrophils/Leukocytes in Pleural fluid

115

288

3.06

25.45

1.4

26.70

21.28

1.04

100

258

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1369

13920

0.73

25.30

1.5

—

6.08

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

25.30

1.1

0.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

242

877

2.12

25.08

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1920

11444

1.31

25.03

2.7

1.8

413.20

371.04

nmol/l

12.56

1812

10447

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

237

866

2.10

24.07

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

232

841

2.12

24.05

1.5

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

489

5986

0.62

24.02

1.6

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

228

822

2.13

23.97

1.4

13.25

13.54

u/l

0.30

223

788

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

582

2814

1.60

23.77

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

327

1347

1.87

23.69

4.8

3.6

13.26

12.66

index

0.31

235

616

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

437

1966

1.71

23.59

1.4

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2144

13063

1.28

23.59

3.0

3.2

210.77

228.15

ng/l

1.02

1966

12021

(3011412) CD3 cells [#/volume] in Blood

202

705

2.20

23.04

2.0

1140.71

1118.36

e6/l

0.10

185

623

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1418

14138

0.75

22.79

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

443

5476

0.61

22.68

1.6

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

199

701

2.18

22.21

1.5

1.4

—

(3021901) Oxygen saturation in Capillary blood

620

3093

1.55

22.15

3.0

89.30

89.57

0.39

604

3012

(3023383) Lactate [Moles/volume] in Pleural fluid

120

335

2.75

22.00

1.3

3.52

3.25

mmol/l

0.32

107

302

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

506

2415

1.62

21.83

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5669

48571

0.85

21.56

2.2

2.3

228.52

228.87

u/l

0.01

5373

45640

(3005322) IgE [Units/volume] in Serum or Plasma

733

8058

0.68

21.49

1.2

1.3

256.66

250.00

u/ml

0.05

668

7510

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

191

675

2.17

21.17

1.5

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

648

3309

1.51

20.82

3.9

3.3

7.86

7.79

mmol/l

0.21

639

3231

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

287

1184

1.86

20.76

1.1

—

(3024471) HLA-A [Type]

119

342

2.67

20.68

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

6509

55041

0.86

20.58

4.2

11.26

8.02

mg/mmol

4.30

4243

34347

(46235355) HIV 1 and 2 tests - Meaningful Use set

2225

13852

1.25

20.32

1.5

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

494

2393

1.59

20.08

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

779

2.05

19.90

1.5

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

667

3460

1.49

19.88

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

662

3429

1.49

19.87

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

171

595

2.21

19.73

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

171

595

2.21

19.73

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

300

3946

0.58

19.69

1.4

1.7

4.80

4.64

mg/l

0.09

252

2953

(3024932) HLA-DR beta [Type]

116

338

2.63

19.66

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

226

877

1.98

19.62

2.9

2.1

14.60

16.17

9.95

226

877

(3008898) HLA-B27 [Presence]

256

3501

0.55

19.38

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

127

390

2.50

19.38

2.7

2.6

35.71

43.14

4.22

196

(42529406) Shigella sp [Presence] in Stool by Culture

665

3467

1.48

19.34

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

6.38

19.12

1.1

1.0

3.15

1.55

ug/l

1.06

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

160

3.40

18.69

1.4

11.03

10.63

0.04

(3008037) Lactate [Moles/volume] in Venous blood

735

3935

1.44

18.65

3.7

3.2

1.71

1.62

mmol/l

1.14

724

3844

(3015171) Extractable nuclear Ab [Units/volume] in Serum

453

5302

0.65

18.22

1.2

1.90

0.71

u/ml

0.71

430

(3026051) Granulocytes/Leukocytes in Pleural fluid

239

2.89

18.15

1.3

1.4

24.95

26.69

0.20

193

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.43

18.01

2.3

4.5

1.55

1.46

mg/l

0.08

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

7.40

17.95

1.6

1.0

86.30

25.12

umol/24h

0.64

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

260

1091

1.83

17.91

1.6

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

611

3187

1.48

17.76

1.2

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

155

3.36

17.62

1.3

49.13

255.03

u/l

0.46

100

(4094501) Cardiovascular stress test using bicycle ergometer

359

4386

0.62

17.53

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

156

550

2.18

17.49

1.6

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

156

550

2.18

17.49

1.6

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

156

550

2.18

17.49

1.6

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

156

552

2.17

17.34

1.6

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

282

1226

1.77

17.30

1.4

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

689

3704

1.44

17.13

5.0

4.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

455

2247

1.56

17.09

1.7

1.6

0.90

0.87

g/l

0.15

337

1757

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1184

11649

0.76

17.08

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

271

1171

1.78

16.98

1.6

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

440

5103

0.65

16.96

1.5

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.40

16.82

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

382

1821

1.61

16.67

1.3

312.73

280.53

u/ml

1.10

248

1154

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

241

1011

1.83

16.65

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

241

1011

1.83

16.65

1.5

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

241

1011

1.83

16.65

1.5

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1940

12158

1.24

16.56

2.8

2.3

0.59

0.45

e6/l

2.00

1893

11635

(3042631) Mycobacterium sp identified in Specimen

355

1671

1.63

16.31

2.3

3.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

116

374

2.38

16.05

1.7

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

197

2.96

16.04

2.1

1.3

22.68

24.69

u/l

0.09

176

(3022475) Manganese [Moles/volume] in Blood

5.70

15.77

1.4

1.2

0.16

umol/l

0.31

(3023420) DNA double strand Ab [Units/volume] in Serum

523

5765

0.69

15.57

1.6

1.7

7.74

7.04

iu/ml

0.21

122

1371

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

15985

126151

0.87

15.50

35.1

15.0

77.46

76.26

ml/min/173m2

11.63

15256

116421

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

113

367

2.36

15.40

1.7

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

324

1513

1.65

15.39

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

324

1514

1.65

15.35

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

324

1514

1.65

15.35

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

324

1514

1.65

15.35

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

113

368

2.35

15.31

1.7

1.2

—

(3003181) Sodium [Moles/volume] in Urine

556

2948

1.45

14.93

1.4

57.63

61.78

mmol/l

1.47

389

2366

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

698

1.95

14.82

1.3

1.2

84.02

83.91

0.01

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

337

2.39

14.71

2.5

1.9

31994.80

35308.72

u/ml

0.03

(3001019) Free T4 and TSH panel - Serum or Plasma

358

4203

0.65

14.67

1.6

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

164

3.04

14.41

1.3

1.1

60.29

65.82

ug/l

1.63

164

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

368

4276

0.65

14.36

1.7

1.9

46.02

43.51

nmol/l

0.83

348

4147

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

145

539

2.06

14.31

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

145

539

2.06

14.31

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

377

4339

0.66

14.05

1.6

15068.02

14823.41

e6/l

0.04

260

3096

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

287

1332

1.66

14.01

1.2

71.70

56.23

u/l

1.47

262

1141

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

204

861

1.82

13.91

2.4

2.3

32.91

28.44

iu/ml

0.18

108

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

471

2453

1.48

13.89

1.1

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.97

13.83

1.5

—

(40761511) CBC panel - Blood by Automated count

16856

132296

0.87

13.72

30.0

14.1

—

6.27

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

489

2576

1.46

13.62

1.3

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

14.13

13.60

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

112

385

2.23

13.47

6.0

1.2

35.12

251.18

u/ml

3.78

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

127

3.26

13.43

1.4

72.90

65.27

0.90

104

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

235

2961

0.60

13.16

1.2

43.07

51.46

u/ml

0.33

273

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

368

4198

0.66

13.15

1.2

1.3

25.19

45.38

u/ml

0.69

212

(3037522) Nuclear Ab [Titer] in Serum

2069

18598

0.83

12.96

1.3

1.4

472.19

539.67

titre

0.95

461

4237

(3010375) cycloSPORINE [Mass/volume] in Blood

129

481

2.06

12.69

32.7

31.1

125.72

113.25

ug/l

1.34

106

388

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

17333

129066

1.15

12.69

34.0

15.4

37.89

24.78

mg/l

307.65

16560

105671

(3020393) Adenovirus Ag [Presence] in Stool

105

3.43

12.66

1.4

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

11.48

12.50

1.1

1.0

—

(3022313) Gas panel - Capillary blood

1111

6745

1.27

12.45

3.9

3.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1334

0.43

12.35

1.0

39.80

43.51

ng/l

0.27

915

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

286

3392

0.64

12.35

1.7

1.9

197.89

202.68

pmol/l

0.36

271

3202

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4633

31989

1.14

12.33

1.8

19807089.67

31782550.74

pmol/l

0.87

3827

26216

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1331

0.43

12.28

1.0

730.35

718.97

ng/l

0.08

892

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1326

0.44

12.17

1.0

304.89

336.43

ng/l

0.39

923

(3045716) Anion gap in Serum or Plasma by calculation

336

1680

1.54

12.10

3.6

2.9

11.44

10.64

mmol/l

2.68

330

1662

(3037756) Immunofixation for Serum or Plasma

516

2814

1.41

11.97

1.5

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.24

11.82

4.2

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

193

2.66

11.80

1.4

1.2

2.42

0.82

mmol/l

0.80

112

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

169

2.76

11.56

1.4

1.2

16263.33

1043.75

u/ml

—

(4034850) Laboratory test

444

4768

0.71

11.48

14.1

10.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

894

5336

1.29

11.48

3.1

2.9

24.31

24.91

mmol/l

3.65

876

5249

(40761539) Cells [Type] in Urine sediment by Light microscopy

279

2.33

11.45

1.3

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

175

751

1.79

11.40

1.6

1.5

6.71

7.62

u/l

0.30

136

603

(3042733) HLA Ab [Presence] in Serum

116

435

2.04

11.29

2.2

5.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

870

5186

1.29

11.28

3.9

3.8

24.72

24.90

mmol/l

0.76

778

4704

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.15

11.21

1.7

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

158

2109

0.57

11.15

4.0

5.0

325.70

349.67

umol/l

1.28

135

1819

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

195

2460

0.60

11.06

1.4

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

121

465

1.99

11.03

1.4

1.3

2069639.38

2125487.22

iu/ml

—

(3052592) Norovirus Ag [Presence] in Stool

246

2.40

11.02

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

353

3916

0.68

10.97

1.2

1.3

5.88

6.49

u/ml

0.08

587

(3006184) Hemoglobin [Mass/volume] in Capillary blood

639

3667

1.34

10.88

2.3

2.2

119.80

131.20

g/l

23.42

498

2814

(3027923) C peptide [Moles/volume] in Serum or Plasma

196

886

1.70

10.69

1.4

1.06

1.26

nmol/l

2.35

152

636

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

3.34

10.67

1.2

1.4

1.39

0.93

ml/s/173m2

1.40

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

177

778

1.75

10.67

1.2

169.83

86.40

u/l

2.59

155

659

(3000494) Fungus identified in Specimen by Culture

2479

16543

1.16

10.55

1.6

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

357

3921

0.69

10.53

1.2

1.3

4.92

5.76

u/ml

0.15

380

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

2121

0.58

10.48

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4239

29365

1.13

10.47

1.8

1.7

2.31

1.23

mg/l

27.98

3530

22962

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

107

3.15

10.46

2.0

1.2

65.95

106.75

ng/l

1.40

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

205

2519

0.62

10.44

1.8

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

144

600

1.84

10.37

2.2

5.4

62.83

1440.43

mg/l

1.33

112

409

(3016244) Insulin [Units/volume] in Serum or Plasma

126

503

1.92

10.34

2.2

3.2

15.71

25.27

mu/l

4.09

119

471

(40758358) Immune stain study

+∞

10.30

1.0

0.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

9332

67508

1.10

10.27

2.4

2.2

88.95

95.70

pmol/l

35.91

5668

35132

(3020717) Zinc [Moles/volume] in Serum or Plasma

147

620

1.82

10.20

1.8

1.4

28.53

20.63

umol/l

1.90

134

566

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

171

756

1.73

10.13

1.2

42.80

22.69

u/l

2.91

147

627

(3026250) Tacrolimus [Mass/volume] in Blood

126

509

1.90

10.00

41.9

40.6

6.63

7.36

ug/l

4.98

111

461

(3040151) Glucose [Moles/volume] in Capillary blood

330

1719

1.47

9.87

7.1

11.8

7.52

7.60

mmol/l

0.13

284

1422

(3000330) Specific gravity of Urine by Test strip

1207

7601

1.23

9.82

4.8

3.4

1.02

ratio

2.28

1102

6891

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

147

1927

0.58

9.76

1.1

1.93

1.39

u/ml

0.24

1055

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

9.37

1.0

0.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

304

1578

1.48

9.28

1.3

1.36

1.44

nmol/l

0.63

274

1440

(3041918) Cholesterol [Moles/volume] in Pleural fluid

247

2.26

9.27

1.3

1.2

1.42

1.45

mmol/l

0.09

129

(3019150) Specific gravity of Urine by Refractometry

4020

33696

0.89

9.26

4.4

1.02

1.11

kg/l

0.81

2895

22046

(3020876) Protein [Mass/time] in 24 hour Urine

320

1682

1.46

9.18

2.4

2.1

1.17

1.34

g/24h

0.53

211

932

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

117

2.88

9.06

1.1

1.2

0.06

0.45

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

230

1132

1.56

9.02

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

238

1183

1.54

8.94

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

162

740

1.68

8.61

1.3

1.2

288.34

378.64

u/l

0.56

150

679

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

538

3122

1.33

8.59

1.4

1.5

0.81

0.85

nmol/l

0.48

472

2600

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

230

1146

1.54

8.57

1.2

26.00

123.64

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

191

912

1.61

8.54

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

267

2971

0.68

8.54

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

230

1147

1.54

8.54

1.2

121.05

190.79

titre

1.00

189

(3023103) Potassium [Moles/volume] in Serum or Plasma

17492

136220

0.89

8.51

40.4

19.4

3.96

4.00

mmol/l

51.17

17257

133088

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

127

544

1.79

8.46

2.1

0.65

0.73

e9/l

0.41

122

513

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

347

3679

0.72

8.42

1.2

1.3

1.90

19.38

u/ml

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

927

5773

1.24

8.42

2.1

2.3

463.89

644.29

ug/l

0.91

895

5484

(3008401) Mugwort IgE Ab [Units/volume] in Serum

119

1581

0.57

8.39

1.1

1.27

1.14

u/ml

0.11

657

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

542

3167

1.32

8.26

1.5

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2087

18099

0.87

8.14

4.6

5.5

32.98

32.69

0.54

1319

11890

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

324

3436

0.72

7.90

1.3

585.12

555.15

mg/l

0.42

317

3266

(3003888) Timothy IgE Ab [Units/volume] in Serum

127

1626

0.59

7.80

1.1

5.10

3.12

u/ml

0.57

784

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

459

4609

0.76

7.79

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.75

7.75

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

2334

15866

1.14

7.59

1.9

2.3

236.91

142.89

ug/g

17.74

1897

12468

(44813793) Dust mix specific IgE antibody measurement

904

0.47

7.47

1.1

—

(3004451) EKG impression Narrative

181

883

1.57

7.47

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

208

1049

1.52

7.40

1.9

1.7

1531.80

3174.94

u/l

0.60

397

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

324

3395

0.73

7.37

1.2

2.85

5.02

u/ml

0.72

228

(3019550) Sodium [Moles/volume] in Serum or Plasma

17483

135957

0.90

7.29

40.3

19.3

138.83

139.80

mmol/l

307.65

17261

133027

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.02

7.13

1.2

1.0

1.07

0.90

u/field

0.76

(3028300) Cannabinoids [Presence] in Urine

189

2165

0.66

7.11

1.4

1.9

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

204

1036

1.51

7.05

1.1

1.0

296.45

285.55

mg/l

1.09

187

942

(3027008) Opiates [Presence] in Urine

189

2158

0.67

7.00

1.4

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

189

2152

0.67

6.91

1.4

1.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

293

3081

0.72

6.85

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

283

2991

0.72

6.83

1.3

1.4

15.40

26.15

e6/l

1.06

203

2268

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

148

704

1.61

6.83

1.7

2.0

2.35

2.65

u/field

0.21

115

471

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

288

3033

0.72

6.80

1.4

2046.10

1557.12

e6/l

0.17

222

2447

(3016879) Cocaine [Presence] in Urine

176

2020

0.66

6.71

1.4

1.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

117

526

1.70

6.70

2.1

1.9

265.78

232.29

e6/l

0.52

102

455

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.30

6.50

1.5

1.2

2.13

1.40

pmol/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

999

0.53

6.47

1.2

1.4

141.40

175.85

pmol/l

1.70

999

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

225

1188

1.45

6.46

1.9

2.1

1.99

3.88

u/field

0.45

135

640

(3006245) CD3-CD19+ cells/cells in Blood

250

2.02

6.46

2.1

1.9

13.13

8.98

1.21

229

(3027944) Amphetamines [Presence] in Urine

189

2120

0.68

6.43

1.4

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

142

1686

0.64

6.40

1.5

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

791

7279

0.82

6.38

1.2

144.07

130.91

u/ml

0.35

243

2739

(4024509) Urine culture

768

7085

0.82

6.36

2.1

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

196

1013

1.48

6.28

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

715

4480

1.23

6.23

2.7

1.5

2.76

1.56

ratio

1.53

427

2558

(3007164) IgA [Mass/volume] in Serum or Plasma

3410

23957

1.11

6.22

1.5

1.4

2.81

2.64

g/l

3.69

2067

13838

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

293

3028

0.74

6.17

1.2

3.87

3.86

mmol/l

0.06

280

2873

(3004716) Salmonella sp identified in Stool by Organism specific culture

778

4931

1.21

6.06

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1258

0.60

6.01

1.1

4.01

3.09

u/ml

0.29

629

(3000060) B lymphocytes [#/volume] in Blood

171

2.19

5.93

1.9

1.88

0.16

e9/l

0.83

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

301

1699

1.36

5.93

1.4

1.2

0.19

0.20

nmol/l

0.08

232

1391

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

294

3017

0.74

5.92

1.1

1.2

3.04

3.34

0.18

309

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

1403

0.62

5.90

1.1

1.10

1.06

u/ml

0.03

700

(3021788) Differential panel - Synovial fluid

309

3129

0.75

5.69

1.5

—

0.94

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1663

11269

1.14

5.68

3.7

4.0

91.67

94.66

ng/l

0.70

1444

9557

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

2.27

5.66

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

182

2.10

5.49

1.9

1.2

7.87

343.38

pmol/l

0.58

(3014271) Vancomycin [Susceptibility]

158

809

1.50

5.37

2.8

3.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

152

773

1.51

5.34

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1074

0.60

5.29

1.1

0.37

0.44

u/ml

0.10

376

(3048879) Bone marrow aspiration report

244

1.91

5.20

1.6

1.2

2.00

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

884

0.56

5.18

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

327

1.78

5.17

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2156

18155

0.90

5.17

11.7

7.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

121

1413

0.65

5.14

1.1

—

0.52

—

(40758292) HTLV I+II Ab panel - Serum

108

2.41

5.13

1.5

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

246

1.90

5.09

1.6

1.1

2.30

2.51

ug/l

0.14

168

(3024891) Influenza virus A+B Ag [Presence] in Specimen

476

2922

1.25

5.09

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.68

5.04

1.1

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

504

1.61

5.02

2.6

2.7

4.72

5.07

kpa

3.09

106

504

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

504

1.61

5.02

2.6

2.7

10.06

10.21

kpa

0.25

106

504

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

11.47

5.02

1.1

1.0

45.33

20.17

umol/l

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

110

530

1.59

4.94

2.1

1.9

544.07

448.40

e6/l

1.11

433

(3008536) Aspergillus sp Ab [Presence] in Serum

190

2.01

4.94

1.9

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

237

1330

1.37

4.92

2.1

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

439

4171

0.80

4.92

1.5

4.70

3.10

iu/ml

0.18

110

816

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

168

889

1.45

4.89

1.4

1.5

12.55

13.98

umol/l

1.86

158

829

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

328

1934

1.30

4.87

1.4

1.3

0.66

2.36

nmol/l

0.90

312

1865

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.73

4.84

1.8

2.5

—

(3017732) Neutrophils [#/volume] in Blood

2384

16661

1.11

4.79

4.7

2.8

4.76

4.60

e9/l

0.38

2052

14015

(3003329) Lymphocytes/Leukocytes in Synovial fluid

138

1543

0.68

4.75

1.5

28.63

28.59

0.00

970

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.90

4.73

4.6

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

192

2024

0.72

4.71

1.6

1.5

62.52

59.26

0.53

119

1288

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

168

2.05

4.68

1.4

1.5

—

(44786800) Granulocytes/Leukocytes in Body fluid

128

2.21

4.65

1.4

1.3

35.45

27.56

0.57

(40763590) HLA-DQ beta [Type]

12.23

4.62

1.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

491

0.45

4.59

2.4

2.7

152.19

148.18

nmol/l

0.08

434

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.58

4.55

1.0

1.3

33.60

41.89

mg/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

100

1181

0.65

4.54

1.0

1.1

2.95

3.39

u/ml

0.17

519

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

286

1674

1.31

4.52

1.4

1.3

—

nmol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

345

3331

0.79

4.49

1.7

1.9

4.64

11.00

iu/l

0.98

124

1305

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

781

5101

1.18

4.47

2.7

1.5

39.59

36.40

mg/l

0.74

669

4297

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

116

1321

0.67

4.42

1.1

—

30.04

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1224

10549

0.88

4.38

2.1

2.3

12.10

15.14

nmol/l

27.73

1072

9592

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

331

1987

1.28

4.33

1.4

1.3

0.16

0.25

nmol/l

1.01

140

(3014148) Varicella zoster virus Ab [Titer] in Serum

115

1305

0.67

4.32

1.1

—

(40760410) HLA-B [Type] by High resolution

10.19

4.30

1.0

1.2

—

(40760409) HLA-A [Type] by High resolution

10.19

4.30

1.0

1.2

—

(46236302) HLA-C [Type] by High resolution typing

10.19

4.30

1.0

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

151

1624

0.71

4.23

1.4

71944.77

143571.46

e6/l

0.99

1101

(3034860) Kappa light chains.free [Mass/volume] in Serum

780

5120

1.17

4.22

2.7

1.5

63.17

46.10

mg/l

1.44

667

4322

(3009261) Glucose [Presence] in Urine by Test strip

10021

74240

1.06

4.21

4.5

4.1

0.87

0.17

estimate

0.59

2336

13890

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

103

510

1.55

4.19

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

138

1499

0.70

4.11

2.0

2.2

1.50

7.49

titre

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1116

0.66

4.09

1.0

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

438

4074

0.82

4.08

1.6

0.24

g/l

0.06

415

3884

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

168

1764

0.73

4.08

1.1

13.39

19.07

au/ml

0.52

334

(3028707) Methadone [Presence] in Urine by Screen method

1004

0.64

4.08

1.6

2.4

—

(3047189) Immunofixation for 24 hour Urine

460

1.56

4.04

1.5

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

151

1610

0.71

4.04

1.1

2.89

2.87

0.01

189

(3021601) Nitrite [Presence] in Urine by Test strip

9830

72839

1.06

4.03

4.5

4.0

0.00

estimate

0.34

2382

14506

(3013862) HLA-DP [Type]

8.74

4.01

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

292

1.70

3.91

1.7

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

928

6210

1.15

3.91

2.2

1.4

3.81

3.75

g/l

0.52

832

5571

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

813

5392

1.16

3.88

2.2

1.4

10.22

10.11

g/l

0.28

707

4711

(3004616) Nuclear Ab [Presence] in Serum

180

1854

0.74

3.88

1.2

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

701

1.44

3.86

1.1

96.77

81.81

u/l

1.05

126

599

(3044889) 12 lead EKG panel

12934

96667

1.06

3.85

4.9

4.4

0.50

3042.98

1.18

251

(3008295) Osmolality of Serum or Plasma

252

1489

1.30

3.79

1.2

1.4

274.26

276.30

mosm/kgh2o

0.74

198

1098

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

928

6225

1.15

3.79

2.2

1.4

4.20

4.23

g/l

0.69

833

5590

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

131

698

1.44

3.78

1.1

37.75

21.76

u/l

2.08

123

594

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

114

1260

0.69

3.78

1.1

—

53.70

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

929

6234

1.15

3.77

2.2

1.4

7.55

7.49

g/l

0.51

832

5590

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

453

4162

0.83

3.75

1.6

1.18

1.20

g/l

0.57

433

3965

(3037692) Legionella sp identified in Specimen by Organism specific culture

385

1.59

3.72

1.5

1.4

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.37

3.71

1.3

1.1

1.00

0.75

u/field

—

(40757494) Bilirubin.total [Moles/volume] in Blood

140

759

1.41

3.68

2.4

2.0

99.18

18.37

umol/l

1.44

(3008116) Ketones [Moles/volume] in Urine by Test strip

327

1.64

3.67

1.2

1.4

0.26

0.29

mmol/l

0.18

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

117

614

1.46

3.67

1.8

1.7

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

510

0.52

3.66

1.3

1.4

55.50

57.79

0.12

445

(3039162) Centromere protein B Ab [Units/volume] in Serum

164

1696

0.74

3.66

1.2

1.3

19.24

56.57

u/ml

—

110

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

978

0.66

3.65

1.2

1.3

0.31

1.22

u/ml

4.15

607

(3041096) Erythrocytes [Presence] in Urine by Automated

5124

37330

1.07

3.62

4.4

3.5

0.20

0.29

estimate

0.28

1932

11263

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

1257

0.70

3.60

1.1

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

133

2.01

3.56

1.1

22.23

20.31

u/l

0.18

(3001964) Herpes simplex virus Ag [Presence] in Specimen

266

1.70

3.54

1.5

1.6

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.19

3.50

1.8

1.5

1.34

1.39

umol/l

0.17

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1050

0.68

3.49

1.8

1.9

116.03

106.13

ng/l

0.40

1050

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.43

3.48

5.5

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

181

1036

1.34

3.45

1.2

10.65

9.39

mmol/l

2.67

164

973

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

656

0.59

3.45

1.2

1.1

—

1.00

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

750

0.62

3.43

1.1

—

(3014891) Appearance of Pleural fluid

184

1.83

3.41

1.7

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

322

1.62

3.41

1.2

—

(3002619) Bacteria identified in Specimen by Culture

352

1.59

3.40

1.2

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

138

1447

0.73

3.40

1.2

7.88

7.61

mmol/l

0.46

124

1222

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

841

0.64

3.38

1.2

1.1

51.76

43.44

mg/l

0.70

726

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

870

5861

1.14

3.37

2.3

1.4

3.05

2.89

g/l

4.38

774

5218

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

797

0.64

3.27

1.0

1.1

12.67

9.18

iu/ml

0.32

172

(3012565) Volume of 24 hour Urine

116

624

1.42

3.24

1.9

1704.27

1957.97

2.39

107

540

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

672

0.61

3.22

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

586

0.59

3.22

1.1

3.09

6.60

u/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

9932

73900

1.05

3.21

4.5

4.1

7.57

4.16

estimate

0.89

2458

14956

(3024263) Appearance of Synovial fluid

810

0.65

3.18

1.4

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

879

0.67

3.10

1.1

6.14

7.13

nmol/l

0.09

165

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

136

1.91

3.04

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.66

3.03

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

153

1.85

3.01

1.3

1.2

56.50

109.57

ug/l

3.33

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

207

2013

0.78

3.01

1.1

1.2

3.80

10.55

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

132

737

1.37

3.00

2.4

2.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

134

1380

0.74

2.98

1.1

1.73

1.51

iu/ml

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.55

2.97

1.0

1.1

8.53

9.08

0.26

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

159

1597

0.76

2.97

1.2

27.37

49.06

u/ml

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

797

0.66

2.97

1.1

391.11

289.53

mg/l

1.47

719

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

102

547

1.43

2.93

1.6

1.7

5.78

8.12

nmol/l

0.21

451

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

364

0.50

2.92

1.3

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.60

2.91

1.1

1.0

258.25

306.33

nmol/l

0.43

(3024139) IgG subclass 3 [Mass/volume] in Serum

228

1382

1.26

2.90

1.4

0.43

g/l

0.01

150

1017

(3028192) IgG subclass 2 [Mass/volume] in Serum

228

1383

1.26

2.89

1.4

3.04

3.00

g/l

0.10

149

1014

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.50

2.87

1.0

1.1

36.05

35.68

0.13

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.50

2.87

1.0

1.1

21.46

21.41

0.01

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

136

0.28

2.87

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

583

0.62

2.81

1.1

68.20

605.29

ng/l

—

153

(3034274) Bile acid [Moles/volume] in Serum --fasting

119

662

1.38

2.80

2.6

1.6

39.79

9.05

umol/l

2.88

479

(42529582) MDA5 Ab [Presence] in Serum by Line blot

467

0.57

2.79

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

467

0.57

2.79

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

467

0.57

2.79

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

467

0.57

2.79

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

222

1349

1.26

2.79

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

227

1384

1.26

2.77

1.4

6.73

6.87

g/l

0.21

149

1014

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1998

14219

1.08

2.74

2.2

2.5

5.35

7.92

ug/l

10.21

1706

12435

(3029937) Albumin [Presence] in Urine by Test strip

5654

41601

1.05

2.74

4.7

4.3

0.00

estimate

0.19

2056

13209

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.35

2.73

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

662

4453

1.14

2.70

2.4

1.5

0.06

0.01

g/l

0.66

588

4026

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.03

2.68

1.0

1.1

7.75

17.00

iu/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

140

805

1.33

2.68

1.3

31.34

33.79

u/l

0.35

113

584

(3038177) Helicobacter pylori Ab [Presence] in Serum

298

1881

1.21

2.65

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

236

0.42

2.62

1.5

56.32

54.95

ug/l

0.04

236

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

928

0.71

2.62

2.2

1.8

486.16

340.30

mu/l

0.88

712

(3025018) Bordetella pertussis Ab [Titer] in Serum

727

0.67

2.58

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

474

0.60

2.56

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

106

1101

0.73

2.56

1.1

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

825

0.69

2.55

1.8

1.4

7.58

5.94

u/l

0.32

716

(3015736) pH of Urine

7905

58732

1.05

2.53

3.9

3.6

6.21

6.23

1.04

4296

31934

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

705

0.67

2.52

1.5

983.09

1023.47

mu/l

0.10

557

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

315

0.51

2.52

3.6

3.3

8.57

7.66

mg/l

0.33

253

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1054

0.73

2.52

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

101

1052

0.73

2.49

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.78

2.47

4.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.78

2.47

1.3

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1033

0.73

2.47

1.1

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

724

4932

1.13

2.46

1.6

30.17

23.05

u/ml

0.97

163

997

(3045683) HLA typing for celiac disease panel - Blood or Tissue

105

588

1.37

2.42

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

105

1079

0.74

2.39

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

1744

14293

0.93

2.38

3.0

2.0

0.01

estimate

0.20

288

2824

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

160

1.72

2.38

1.9

1.7

—

(3006270) Folate [Moles/volume] in Blood

194

1186

1.25

2.37

1.2

345.59

341.71

nmol/l

0.09

153

957

(3018333) Ribosomal P Ab [Presence] in Serum

989

0.73

2.36

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

637

1.35

2.35

1.1

1.0

—

(4212803) Bone marrow aspirate examination

2.06

2.35

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

472

0.61

2.35

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

593

0.66

2.34

1.1

1.87

1.09

u/l

0.57

266

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1005

0.74

2.34

1.1

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

771

5290

1.12

2.33

2.3

1.5

0.83

0.36

g/l

3.66

652

4524

(3029396) Erythrocyte agglutination [Presence] in Blood

2.18

2.32

1.7

2.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

581

0.66

2.30

1.0

1.1

1555.06

1611.81

miu/ml

0.14

581

(3025130) Human papilloma virus identified in Specimen

117

1174

0.76

2.27

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

531

0.65

2.24

1.2

1.3

40.60

40.26

g/l

0.05

282

(3034891) Synovial lining cells/cells in Synovial fluid

785

0.71

2.23

1.5

2.05

4.51

1.81

165

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1939

13901

1.07

2.23

1.7

1.8

1.60

1.54

2.38

1649

11959

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

181

1.65

2.23

1.2

74.00

103.39

ng/l

0.58

128

(3027456) Digoxin [Moles/volume] in Serum or Plasma

540

3640

1.14

2.21

3.3

0.85

0.81

nmol/l

0.69

440

2957

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

123

718

1.31

2.19

2.2

41.84

143.75

ug/min

2.14

172

(3016038) Potassium [Moles/volume] in Urine

177

1083

1.25

2.18

1.3

1.2

35.29

33.32

mmol/l

0.55

161

912

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

595

4040

1.13

2.17

2.4

1.5

0.00

g/l

-0.00

549

3766

(3038026) Centromere Ab [Units/volume] in Serum

117

1163

0.77

2.14

1.2

5.00

51.30

u/ml

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

128

1256

0.78

2.12

1.6

1.9

662.86

3191.43

titre

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

588

0.68

2.12

1.3

1.2

0.64

0.55

ratio

0.72

366

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

306

1.48

2.11

2.8

2.5

7.57

7.88

mmol/l

0.25

192

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.09

2.10

1.7

1.2

0.07

g/l

0.17

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

628

4289

1.12

2.10

2.3

1.5

0.01

0.00

g/l

0.90

551

3775

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

285

0.54

2.09

2.7

2.5

130.00

163.53

au/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

104

1.84

2.08

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

105

605

1.33

2.07

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

201

0.46

2.03

1.2

1.3

3.72

7.06

mmol/l

—

100

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.10

2.02

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

151

1.67

2.01

1.7

1.9

1.07

1.08

mmol/l

0.01

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.15

2.01

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

376

0.61

1.98

1.5

2.0

9.38

8.70

mg/l

0.34

313

(3033099) Centromere Ab [Titer] in Serum

366

0.61

1.97

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

712

0.72

1.95

3.5

5.6

324.63

382.95

u/ml

—

119

(3026470) Cobalt [Mass/volume] in Blood

112

1104

0.77

1.95

2.1

2.2

3.55

3.56

ug/l

0.01

101

1030

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.64

1.94

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.16

1.92

1.1

1.5

1.00

1.03

u/field

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.78

1.92

6.0

3.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

121

0.38

1.92

1.2

1.7

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

101

586

1.32

1.92

2.8

1.6

216.66

201.19

u/l

0.62

101

579

(3026493) Urate [Moles/volume] in Serum or Plasma

4817

38076

0.96

1.91

3.1

2.5

359.89

354.63

umol/l

2.50

4197

32939

(40762814) Titanium [Mass/volume] in Blood

332

0.60

1.87

2.4

2.6

3.32

3.28

ug/l

—

129

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

215

1.53

1.86

1.1

1.2

81.63

76.61

0.20

(3028433) Virus identified in Specimen by Culture

360

1.40

1.86

1.1

—

(3004775) Volume in Urine collected for unspecified duration

193

1217

1.21

1.85

2.2

2.3

740.72

666.72

1.04

113

827

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

304

1.43

1.82

1.1

73.29

88.75

1.50

159

(3025577) Chromium [Mass/volume] in Blood

109

1063

0.78

1.77

2.2

2.21

2.35

ug/l

0.17

884

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

220

1413

1.19

1.76

3.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

518

0.69

1.73

1.1

1.0

0.88

0.89

u/ml

0.01

175

(3022621) pH of Urine by Test strip

1387

11309

0.93

1.71

3.0

2.8

6.04

0.00

1068

7827

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.05

1.71

2.1

1.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

0.27

0.95

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

0.21

0.77

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

2.99

2.00

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

1.91

3.48

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

0.86

2.72

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

0.20

1.68

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.10

1.69

1.6

1.4

0.90

2.35

mg/l

—

(3007916) DNA double strand Ab [Titer] in Serum

176

0.48

1.69

1.2

1.3

—

97.45

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

176

0.48

1.69

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

162

1502

0.82

1.68

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

478

0.69

1.67

1.3

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

342

1.39

1.67

2.0

1.9

243.21

190.47

2.52

323

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

116

0.40

1.66

1.3

1.9

0.80

1.69

mg/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

413

0.67

1.65

1.4

1.5

49.07

60.81

ug/l

0.93

327

(3016750) Collection duration of Urine

138

854

1.24

1.63

2.2

2.1

493.32

499.19

min

0.26

640

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3975

31440

0.96

1.62

3.1

2.9

0.79

0.71

ug/l

4.84

2773

20754

(3035320) C reactive protein [Mass/volume] in Body fluid

164

1035

1.21

1.61

2.9

38.86

30.09

mg/l

1.78

131

752

(3023323) Follitropin [Units/volume] in Serum or Plasma

296

2597

0.87

1.60

1.3

37.87

32.81

iu/l

1.38

241

2235

(43055442) Apixaban [Mass/volume] in Serum or Plasma

287

1.41

1.59

1.5

1.7

98.12

116.98

ug/l

0.85

242

(3009871) Measles virus Ab [Titer] in Serum

446

0.68

1.59

1.6

4250.00

4012.05

titre

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

409

0.67

1.58

1.1

1.0

0.29

1.11

u/ml

0.60

112

(3001186) Copper [Moles/volume] in Serum or Plasma

320

1.39

1.57

1.2

16.95

16.28

umol/l

0.66

284

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

344

0.64

1.57

1.4

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

212

1.48

1.57

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

615

4276

1.10

1.56

1.6

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.02

1.55

1.6

1.4

0.70

1.43

mg/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

213

1.47

1.54

1.2

85.06

85.12

0.00

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

182

1.51

1.53

2.4

2.9

0.78

0.54

u/field

0.67

182

(3003740) Influenza virus B Ag [Presence] in Specimen

164

1502

0.83

1.53

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

335

2253

1.14

1.52

1.4

1.3

14.78

9.19

u/l

7.31

266

1761

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

705

5870

0.92

1.52

1.7

1.9

39.98

39.28

u/l

0.38

632

5102

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

279

1855

1.15

1.50

2.0

2.2

36.11

26.03

mg/l

1.69

113

668

(3001729) Color of Synovial fluid

130

0.47

1.49

1.1

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

131

0.47

1.49

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

288

1922

1.15

1.48

2.5

2.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.91

1.45

1.9

1.5

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

205

0.56

1.45

1.1

1.4

41.00

47.60

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

1.68

1.44

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

288

1.38

1.41

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

433

3674

0.90

1.40

1.7

2.0

12.78

11.76

mg/l

0.94

399

3435

(3028679) Herpes simplex virus Ab [Presence] in Serum

548

0.74

1.39

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

125

0.49

1.38

1.3

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

127

0.48

1.37

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

182

0.55

1.37

1.9

2.0

19.28

18.10

umol/l

0.20

182

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

651

0.76

1.37

1.2

1.07

ratio

0.06

538

(3014599) Egg white IgE Ab [Units/volume] in Serum

485

0.72

1.37

1.0

5.00

0.75

u/ml

0.51

122

(3024869) Neuronal Ab [Presence] in Serum

238

1.41

1.37

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.22

1.36

1.3

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

340

0.67

1.34

6.1

9.09

8.61

mmol/l

0.45

340

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

257

0.62

1.34

1.5

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

4698

34935

1.04

1.34

3.7

4.0

0.19

0.17

0.05

413

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

170

0.54

1.33

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

319

2163

1.13

1.32

1.1

2876.58

6290.29

iu/ml

0.23

387

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.94

1.31

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

179

0.55

1.31

1.0

1.1

58.96

33.94

iu/ml

0.46

179

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

380

1.31

1.27

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

290

0.66

1.27

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.42

1.27

1.4

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.42

1.27

2.0

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8052

62654

0.97

1.26

2.5

2.4

74.96

78.74

nmol/l

25.84

7291

55526

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.85

1.25

1.9

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

211

1.41

1.24

1.1

877.78

881.40

titre

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.67

1.24

1.5

22.71

22.81

mmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

204

1350

1.16

1.23

3.1

3.0

39.51

42.50

mg/l

0.08

146

961

(3023410) Appearance of Cerebral spinal fluid

138

1253

0.84

1.23

1.4

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

152

1366

0.85

1.20

1.5

1.6

25.12

26.04

u/ml

0.09

297

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

128

1167

0.84

1.20

1.2

1.3

203.00

529.43

titre

—

105

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

1.18

0.0

1.2

—

1.48

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.11

1.17

2.3

1.1

—

(3013512) EKG study

7027

52699

1.03

1.16

4.3

3.8

0.75

0.72

0.08

149

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

582

0.77

1.16

1.3

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5551

43375

0.97

1.14

4.3

3.9

21.55

24.23

34.17

2827

20602

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

241

1.36

1.13

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

151

0.56

1.12

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7231

54285

1.03

1.11

5.1

4.2

2.85

1.99

ug/l

6.33

6341

49275

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

262

0.67

1.10

1.0

1.1

5.61

9.09

u/ml

0.61

148

(3036071) Salmonella sp Ab [Titer] in Serum

324

0.71

1.09

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

714

1.20

1.08

3.8

4.1

—

(3006462) Nitrate [Presence] in Urine

624

1.21

1.08

3.7

3.3

—

(4211845) Urine protein measurement

107

680

1.20

1.07

3.6

3.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

332

0.71

1.07

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

740

6043

0.93

1.06

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

384

0.74

1.06

1.3

1.4

0.95

1.21

ratio

1.10

227

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

384

0.74

1.06

1.3

1.4

1.00

0.96

ratio

0.13

227

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

384

0.74

1.06

1.3

1.4

0.98

1.17

ratio

0.53

227

(40757373) Influenza virus identified in Isolate

251

1.34

1.06

1.6

—

(3012898) Urea [Moles/volume] in Urine

148

1.45

1.03

1.1

1.4

210.00

160.32

mmol/l

0.64

132

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

312

1.30

1.03

1.1

78.70

87.86

0.84

161

(3006576) Bicarbonate [Moles/volume] in Blood

565

1.22

1.03

4.7

6.5

24.85

25.26

mmol/l

0.29

512

(3003577) Lead [Moles/volume] in Blood

0.46

1.02

1.0

1.3

—

0.15

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

596

0.79

1.02

1.1

19.25

21.67

u/ml

0.25

211

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

380

0.74

1.00

1.3

1.4

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

103

0.52

1.00

1.3

1.8

—

(3034614) HLA Ag [Interpretation]

0.00

0.99

0.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

115

743

1.18

0.99

1.1

1.2

130.03

138.87

nmol/l

1.18

115

743

(3014051) Protein [Presence] in Urine by Test strip

5053

37804

1.03

0.99

3.4

3.1

0.13

0.07

0.82

143

1182

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

5.7

—

0.30

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

790

6414

0.94

0.97

1.1

6.24

10.16

u/ml

0.21

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

245

2089

0.90

0.96

1.1

1.3

169.77

210.71

miu/ml

0.77

815

(3039744) RNA polymerase III Ab [Units/volume] in Serum

110

0.56

0.95

1.0

—

3.77

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

313

0.73

0.92

1.9

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

271

1.30

0.92

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1201

9615

0.95

0.91

1.2

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

612

0.81

0.91

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.08

0.89

5.5

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

318

0.74

0.86

1.3

1.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.99

0.86

5.5

2.3

—

236683.33

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

181

1.35

0.85

3.6

2.6

25.04

47.77

mg/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

106

0.58

0.84

1.0

6.50

7.49

u/ml

—

106

(3033942) Copper [Moles/time] in 24 hour Urine

1.72

0.82

1.5

1.0

2.24

0.38

umol/24h

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

451

0.80

0.81

1.1

94.46

100.08

0.57

347

(3005033) Fetal Nuchal fold Thickness US

314

0.75

0.81

1.3

1.4

1.35

1.28

0.17

212

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

124

1.42

0.81

2.4

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.80

0.0

1.1

—

3712.74

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

189

1291

1.12

0.80

1.1

1.2

96.35

97.02

0.13

175

1202

(3016330) Potassium [Moles/time] in 24 hour Urine

190

0.68

0.79

1.1

1.2

—

80.62

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.50

0.79

1.0

0.01

0.05

u/ml

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

407

0.79

1.1

1.2

8.20

23.83

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.57

0.78

3.8

3.5

28.36

46.93

2.48

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.57

0.78

7.6

7.0

11.14

7.87

0.87

(3010838) Calcium [Moles/time] in 24 hour Urine

303

2520

0.92

0.77

1.8

1.9

4.53

4.92

mmol/24h

1.08

265

2218

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

130

1132

0.88

0.77

1.2

1.3

122.86

80.00

titre

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

422

0.80

0.76

1.3

31.55

37.82

0.55

281

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

356

1.22

0.75

1.1

1.3

2.32

3.18

umol/l

1.64

304

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

865

1.14

0.75

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.46

0.75

1.2

0.14

0.18

nmol/l

0.56

(3023511) Choriogonadotropin [Units/volume] in Urine

471

0.81

0.74

1.4

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

275

0.75

0.74

1.3

1.7

131.62

86.80

au/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

257

1794

1.10

0.74

1.2

3.83

3.81

u/ml

0.01

110

663

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

403

0.80

0.74

1.4

1.6

12.11

9.38

ug/l

1.61

403

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

403

0.80

0.74

1.6

0.33

0.36

ug/l

0.16

270

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

461

0.81

0.73

1.1

1.3

111.14

137.38

nmol/l

0.88

315

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

186

0.70

0.72

1.4

1.6

—

(3018291) Platelet Ab [Presence] in Serum

2.01

0.72

1.0

1.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.01

0.72

1.0

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

519

0.82

0.72

2.7

3.1

30.86

28.44

umol/l

0.89

390

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.78

0.72

1.4

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.78

0.72

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

287

2019

1.09

0.71

1.4

1.3

70.57

60.70

mu/l

0.27

255

1815

(3010937) Rubella virus Ab [Presence] in Serum

1.73

0.70

1.0

—

(3003129) Base excess in Capillary blood by calculation

222

1862

0.91

0.70

2.7

2.1

0.17

0.65

mmol/l

0.99

211

1803

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

113

0.61

0.70

1.1

142.22

90.90

titre

—

113

(3001218) Citrate [Mass/time] in 24 hour Urine

1.91

0.70

2.0

1.4

259.00

420.50

mg/24h

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

305

1.23

0.68

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

852

1.13

0.67

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.82

0.67

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.53

0.66

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

265

1.24

0.66

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

190

1.29

0.65

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.61

0.0

1.3

—

277.07

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

813

6488

0.96

0.61

1.4

1.6

12.34

17.12

iu/ml

0.41

145

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

117

0.65

0.61

1.1

6.15

6.36

mmol/l

—

117

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.61

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.61

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.61

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.61

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.61

0.0

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

252

1778

1.08

0.61

1.2

2.65

3.97

u/ml

2.78

128

828

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

125

1.35

0.61

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

125

1.35

0.61

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

125

1.35

0.61

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

679

1.14

0.60

1.1

5.33

4.43

iu/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

222

0.76

0.60

1.4

1.2

49.89

44.01

mg/l

0.20

188

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

920

7316

0.96

0.59

3.1

4.28

4.43

pmol/l

4.79

820

6460

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

524

3797

1.06

0.59

2.5

2.3

130.34

109.54

ug/min

0.40

303

2177

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

473

1.16

0.59

1.9

1.8

219.70

168.60

3.08

443

(3012494) Peanut IgE Ab [Units/volume] in Serum

247

0.77

0.59

1.0

1.02

1.07

u/ml

0.03

122

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

106

1.37

0.59

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

173

1.28

0.59

1.0

1.1

—

(4268621) Lupus anticoagulant assay

178

1240

1.10

0.58

2.2

2.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

186

0.74

0.58

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

304

2167

1.07

0.58

1.2

51.69

20.35

u/l

1.87

264

1852

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

195

1365

1.09

0.58

1.0

1.1

5.36

4.08

eliau/ml

0.34

527

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

368

1.18

0.58

1.1

—

(4198724) Urine methamphetamine measurement

305

0.80

0.57

1.3

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

271

1.21

0.56

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

161

1351

0.91

0.56

1.1

1.5

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

593

0.86

0.55

1.2

65.67

54.65

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.64

0.55

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

319

0.81

0.54

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

135

1.30

0.53

1.1

1.0

82.45

83.86

ug/l

0.06

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

315

1.19

0.53

1.1

1.2

361.45

274.95

pmol/l

0.55

221

(3020911) Cortisol [Moles/time] in 24 hour Urine

393

1.17

0.53

1.3

1.4

732.08

76.28

nmol/24h

1.19

393

(3046861) Legionella sp Ag [Presence] in Urine

1.40

0.53

1.2

1.1

—

(3019174) dRVVT (LA screen)

104

0.66

0.52

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

150

1044

1.10

0.52

1.2

111.05

103.85

pmol/l

0.85

150

1044

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

264

1884

1.07

0.51

1.3

294.74

345.04

pmol/l

0.40

224

1567

(36660697) Celiac disease serology panel - Serum

1298

10214

0.97

0.50

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

414

0.85

0.49

1.4

1.2

0.32

0.31

g/l

0.15

337

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.37

0.47

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.66

0.46

1.1

1.0

0.06

0.03

u/ml

—

(44806071) Cardiolipin IgM antibody measurement

178

0.77

0.45

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

139

1.27

0.45

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

105

1.31

0.45

1.2

1.1

11.17

10.92

u/l

0.02

105

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13698

105214

0.99

0.44

43.8

18.6

14.79

13.64

307.65

13603

103584

(3002079) Sodium [Moles/time] in 24 hour Urine

636

0.89

0.43

1.2

153.35

168.08

mmol/24h

0.70

636

(44806420) Estimation of glomerular filtration rate

153

1266

0.92

0.43

2.5

2.7

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.07

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.41

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

264

1903

1.06

0.41

1.3

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.36

0.41

1.0

—

(3044927) Protein electrophoresis panel - Urine

230

1652

1.06

0.40

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

348

0.86

0.40

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

182

0.80

0.39

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

131

0.76

0.39

1.5

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

273

1980

1.05

0.36

1.5

1.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

350

1.14

0.36

1.2

1.1

15.41

12.51

pmol/l

0.37

142

(37021550) Renin [Units/volume] in Plasma --upright

264

1.16

0.36

1.1

1.3

168.28

53.68

mu/l

1.12

187

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.63

0.36

1.4

1.5

883.74

549.68

nmol/l

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

229

1654

1.06

0.36

1.1

111.32

116.91

1.93

213

1482

(3013247) Albumin in CSF/Albumin in Serum or Plasma

171

0.80

0.35

1.2

1.1

10.56

8.15

mg/g

0.36

161

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

561

0.90

0.35

2.4

2.3

54.34

54.30

umol/l

0.00

469

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

416

3055

1.04

0.34

1.1

4.76

9.54

eliau/ml

1.78

298

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

724

1.09

0.34

2.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

138

1.22

0.34

2.5

2.4

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.67

0.33

1.0

1.1

—

28.40

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

102

0.75

0.33

1.3

1.4

28.60

46.14

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

292

2336

0.95

0.32

2.3

1.8

331.37

286.74

mu/l

0.66

269

2140

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

117

830

1.08

0.32

1.4

0.32

0.25

nmol/l

0.54

590

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

388

0.89

0.31

1.4

1.2

107.05

113.15

0.91

346

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

266

0.86

0.30

2.4

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

705

5535

0.97

0.29

1.1

221.96

185.18

titre

0.25

144

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

370

0.89

0.29

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

466

1.10

0.29

7.2

7.4

5.76

6.03

kpa

2.08

415

(3017704) Immunofixation for Urine

109

776

1.07

0.28

1.4

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

113

1.22

0.28

1.3

1.7

—

(3020491) Glucose [Moles/volume] in Blood

133

955

1.06

0.28

1.8

2.0

7.79

7.02

mmol/l

1.59

101

644

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

343

0.89

0.27

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.66

0.26

1.0

1.2

193.20

277.24

u/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7173

55156

0.99

0.25

4.6

4.1

0.22

0.48

estimate

0.78

2013

11719

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.74

0.24

1.0

—

(4015189) Microbial culture of sputum

412

0.91

0.24

1.7

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

291

0.89

0.23

1.1

0.63

0.67

umol/24h

0.31

130

(3045462) Protein/Creatinine [Ratio] in Urine

109

1.19

0.23

3.9

4.7

224.07

61.13

mg/mmol

0.45

104

(3050794) Legionella sp Ab [Presence] in Serum

129

0.83

0.23

1.3

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.75

0.22

1.6

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.74

0.22

3.0

3.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

426

0.91

0.22

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

145

0.84

0.22

1.3

1.8

8.29

7.15

mmol/l

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.23

0.22

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

274

0.89

0.22

1.0

1.2

—

360.00

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

147

1180

0.95

0.22

1.3

1.4

0.81

1.28

promille

4.12

121

918

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.22

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.03

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.19

0.21

1.0

1.7

—

2196.67

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

182

1.13

0.21

1.1

1.4

8.55

249349.84

nmol/l

1.08

152

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.21

0.0

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

29.45

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

233

1718

1.04

0.20

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.80

0.20

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

182

1448

0.96

0.20

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

656

1.06

0.19

1.6

1.7

134.95

107.38

umol/l

0.26

319

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

634

1.06

0.19

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

570

4270

1.02

0.18

1.3

1.6

16.60

15.93

iu/ml

0.03

105

(3051387) C reactive protein [Mass/volume] in Capillary blood

392

3065

0.98

0.16

3.5

35.64

26.36

mg/l

4.83

289

2184

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.20

0.16

12.7

8.8

101.55

104.49

g/l

0.62

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3779

28705

1.01

0.16

1.2

1.3

2.05

1.76

u/ml

0.51

923

7592

(3041806) Other cells [#/volume] in Blood by Manual count

0.79

0.16

1.5

0.45

0.50

e9/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

156

0.88

0.16

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

107

0.86

0.14

1.1

—

0.22

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

173

1.10

0.14

1.0

1.1

—

(3034426) Prothrombin time (PT)

351

1.07

0.14

1.2

28.45

28.32

0.04

351

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

329

1.07

0.14

1.2

1.4

1.16

1.18

mmol/l

0.98

329

(40761535) Cells panel - Urine sediment

1487

11472

0.99

0.13

3.4

—

1.70

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.82

0.13

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.82

0.13

1.1

1.2

—

(40768443) Skin Pathology biopsy report

736

5699

0.99

0.12

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

693

0.96

0.12

1.2

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

197

1.09

0.12

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.14

0.12

3.4

2.7

—

(3044009) aPTT.lupus sensitive (LA screen)

0.87

0.12

1.1

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

391

1.06

0.12

6.4

6.7

62.53

70.20

0.85

318

(3018851) Theophylline [Moles/volume] in Serum or Plasma

139

1.10

0.11

1.8

1.7

47.45

47.15

umol/l

0.02

139

(3011335) Digoxin [Mass/volume] in Serum or Plasma

139

1.10

0.11

2.2

2.3

0.64

0.65

ug/l

0.07

139

(3001686) Cold agglutinin [Titer] in Serum or Plasma

243

1.07

0.11

1.7

1.2

153.83

251.81

titre

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

415

1.05

0.11

7.4

7.3

5.73

5.31

kpa

0.66

415

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

115

852

1.03

0.10

2.2

16.13

15.98

nmol/l

0.07

106

781

(4146454) Self-monitoring of blood glucose

257

1927

1.02

0.10

2.8

—

(3045424) Erythrocytes [Presence] in Urine

920

6966

1.01

0.10

3.4

2.0

0.04

0.14

estimate

0.34

224

2154

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

326

1.06

0.10

1.4

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.13

0.10

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

331

0.95

0.10

6.0

7.0

10.25

10.46

0.30

331

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.06

0.09

1.0

1.2

—

mmol/l

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.06

0.09

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

389

2933

1.01

0.09

1.2

1.3

172.00

130.51

titre

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

675

5210

0.99

0.08

2.0

1.6

0.32

mg/l

0.01

290

2534

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

193

1.07

0.08

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

387

2919

1.01

0.08

1.2

1.3

249.52

313.98

titre

0.21

251

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.08

1.0

1.2

—

(4133840) Spirometry

337

0.95

0.08

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.78

0.08

1.0

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

13200

101017

1.00

0.08

4.2

4.6

17.85

12.36

mm/h

193.01

12147

93988

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

653

1.03

0.08

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

730

5532

1.01

0.08

1.2

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.85

0.07

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

435

1.04

0.07

1.4

14.48

16.12

pmol/l

1.57

359

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

436

0.96

0.07

1.2

15.62

11.01

mm/h

1.27

436

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

191

1436

1.02

0.07

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

156

0.93

0.07

1.6

1.7

—

(3020650) Glucose [Presence] in Urine

421

1.03

0.06

1.5

1.7

0.00

0.05

estimate

2.23

421

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

574

0.97

0.06

1.9

1.2

39.00

39.68

g/l

0.44

574

(4195642) Thrombophilia screening test

220

1658

1.01

0.06

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

388

0.97

0.06

1.2

—

(40768446) Kidney Pathology biopsy report

542

0.97

0.06

1.3

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

116

0.92

0.05

1.7

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

510

0.97

0.05

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.91

0.05

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

700

0.98

0.04

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.08

0.03

2.6

2.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

177

1.04

0.02

2.2

2.4

41.89

41.16

umol/l

0.04

151

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

1.04

0.01

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

316

1.02

0.00

1.1

1.3

0.99

53.34

mg/l

1.24

236

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

132

0.98

0.00

1.2

1.1

1.34

1.74

umol/24h

1.94

132

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

191

1.00

0.00

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

185

0.99

0.00

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

149

0.97

0.00

1.3

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.05

0.00

2.1

1.4

464.36

319.35

umol/24h

0.58

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.94

-0.00

1.0

1.2

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.60

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.00

-0.00

1.2

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.48

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

89.50

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.80

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.99

-0.00

1.1

1.3

1.43

1.34

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.96

-0.00

1.0

1.2

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.91

-0.00

1.0

1.2

76.29

84.11

umol/l

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS – Malignant neoplasm of digestive organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of digestive organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints